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ABSTRACT 1 
 2 
 3 
Non-O157 Shiga-toxin producing Escherichia coli (STECs) serovars O145:NM, 4 
O45:H2, O26:H11, O103:H11, O111 (organism was originally ordered from American 5 
Type Culture Collection (ATCC) under accession # BAA-2217, and has since then been 6 
reclassified as O147, see Appendix), O121:H19, and E. coli biotype I surrogates were 7 
individually cultured in tryptic soy broth (TSB) at 37°C for 18 hours. Rifampicin- 8 
resistant (rif-resistant) surrogates were compared to the parent strains listed above. 9 
Stationary phase and acid-adapted organisms were each transferred into phosphate 10 
buffer saline (PBS) acidified with L-lactic acid at pH 2.5, 3.0, and 3.5, and enumerated 11 
for survivors following a 2-hour exposure time. In order to construct a thermal 12 
destruction curve, organisms were transferred into a capillary tube, flame sealed, 13 
submerged in a water bath at 55, 60 and 65 ± 0.5°C, and enumerated for survivors. For 14 
freezing (-20 ± 0.5°C) and refrigerated (4 ± 0.5°C) storage, bacterial strains were 15 
enumerated on days 0, 7, 14, 21, 28, 60, and 90 to determine the response to freezing and 16 
refrigerated storage.  17 
Growth curves of E. coli biotype I surrogates (parent and rif-resistant) were 18 
similar to those of STECs throughout the evaluation. For acid resistance, acid-adapted 19 
organisms at pH 3.0 showed initial log reductions (CFU/ml) ranging from 1.7-2.5, where 20 
organism O26:H11 had the greatest log reduction (2.5). After 2 hours exposure time, 21 
reductions ranged from 5.1-7.4 log CFU/ml. D-values were calculated for each organism 22 
  iii 
at 55, 60 and 65 ± 0.5°C. Acid-adapted organisms at 65°C had D-values ranging from 23 
0.13-0.64 min, with a rif -resistant E. coli biotype I surrogate (BAA-1429 rif) having the 24 
highest D-value at this temperature. For the response to refrigeration and freezing 25 
temperatures, there were no notable trends or patterns observed, and no one single E. 26 
coli biotype I surrogate represented all of the non-O157 STECs. 27 
Organisms were analyzed individually and in sets (surrogates, rif-resistant 28 
surrogates and STECs) to represent a mean. Analyzing the organisms in sets eliminated 29 
certain individual strain-to-strain variation, and showed fewer differences (P < 0.05). 30 
Surrogates analyzed as a mean of the five strains indicate they may be best utilized in 31 
combination to represent all six of the non-O157 STECs.  32 
 33 
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1. INTRODUCTION 271 
 272 
Meat and meat products may contain pathogens that can be associated with 273 
foodborne illness. E. coli O157:H7, a pathogen associated with foodborne illness is 274 
naturally found in the intestinal tract of beef cattle. Through the process of harvesting 275 
cattle, potential pathogens, including E. coli O157:H7, may contaminate the carcass 276 
surface through the necessary procedures required for the conversion of the live animal 277 
into meat. For example, contamination may occur during the removal of the hide, or at 278 
the evisceration stand. E. coli O157:H7 is a human health risk and is naturally occurring 279 
in low numbers. If the potential pathogen remains on the meat or meat product, the 280 
consumer may contract a foodborne illness. E. coli O157:H7 can cause severe illness 281 
including hemolytic uremic syndrome (HUS). In 1992, an outbreak of E. coli O157:H7 282 
attributed to undercooked hamburgers caused hundreds of illnesses and four deaths. 283 
Following the outbreak, many government agencies, academic personnel, and industry 284 
representatives have made advancements into researching and improving the safety of 285 
meat and meat products.  286 
The United States Department of Agriculture-Food Safety and Inspection Service 287 
(USDA-FSIS) has declared E. coli O157:H7 an adulterant in raw ground beef. For this 288 
reason, the meat industry has implemented points in the process of producing meat and 289 
meat products that may reduce or eliminate potential pathogens. Most commonly, 290 
antimicrobial interventions including hot water, lactic acid, acidified sodium chloride, or 291 
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peroxyacetic acid can be applied to carcass surfaces or further processed products to 292 
reduce or eliminate potential pathogens that may be present.  293 
E. coli O157:H7 is not the only potential pathogen that may be found in the 294 
intestinal tract of cattle. Other organisms, including the non-O157 STECs may also be 295 
present, and these can cause foodborne illness in humans. STECs are comprised of many 296 
pathogenic serotypes and E. coli O157:H7 is the most studied. Non-O157 STEC 297 
illnesses may not be as severe as E. coli O157:H7, and vary by serogroup, but the 298 
number of foodborne illnesses caused by these organisms is increasing in the United 299 
States and around the world. Six non-O157 STECs have been shown to cause the 300 
majority of the foodborne illness associated with these organisms (O26, O45, O103, 301 
O111, O121 and O145). The USDA-FSIS has declared these six non-O157 STECs, the 302 
“Big 6,” as adulterants in raw, non-intact beef products, and raw, intact beef products 303 
intended for non-intact products. 304 
Five non-pathogenic E. coli biotype I surrogates, identified previously from 305 
cattle hides have been shown to have similar acid resistance at pH 3.0, 4.0, and 5.0, and 306 
thermal resistance at 55 and 65°C when compared to E. coli O157:H7. For an organism 307 
to be appropriate for use as a surrogate, it is ideally isolated from the same environment, 308 
present when the target pathogen is present, correlated in population densities, and 309 
having the same performance characteristics, for example, growth rate and sensitivity to 310 
microbial intervention methods. In-plant validation studies are used to determine the 311 
effectiveness of a processing facility’s interventions, and their ability to reduce or 312 
eliminate potential pathogens. Given that E. coli O157:H7 is an adulterant, it is not 313 
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approved for use in in-plant validation studies. The non-pathogenic surrogate organisms 314 
that represent E. coli O157:H7 can be taken into a processing facility to validate the 315 
processor’s interventions with reference to E. coli O157:H7.  316 
Since the six non-O157 STECs have been declared adulterants, there is a need to 317 
identify surrogate microorganisms that properly represent the characteristics of the non- 318 
O157 STECs to be used in plant validation studies. The purpose of this study was to test 319 
the appropriateness of the previously identified E. coli biotype I surrogates (used for E. 320 
coli O157:H7) to the six non-O157 STECs using growth characteristics, acid and 321 
thermal resistance, and response to refrigeration and freezing temperatures. 322 
  323 
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2. REVIEW OF LITERATURE 324 
 325 
Foodborne illness as it relates to raw meat and meat products 326 
It is estimated that foodborne diseases cause approximately 76 million illnesses, 327 
325,000 hospitalizations, and 5,000 deaths in the United States (U.S.) each year (30). 328 
The causes of foodborne illness include viruses, bacteria, parasites, toxins, metals, and 329 
prions. More than two hundred diseases are transmitted through food (30). The 330 
symptoms of foodborne illness range from mild gastroenteritis to life-threatening 331 
neurologic, hepatic, and renal syndromes. An annual report from the Centers for Disease 332 
Control and Prevention (CDC) shows that foodborne infections continue to be an 333 
important public health risk in the U.S. (14). Data from Foodborne Diseases Active 334 
Surveillance System (FoodNet), which monitors fifteen percent of the nation’s 335 
population, provide the best measure of foodborne disease in the U.S., and these data 336 
compare rates for different time periods (14). These numbers are an estimation based on 337 
the number of people in the U.S. and those sickened with foodborne infections that have 338 
been confirmed by laboratory tests (14). Foodborne illness surveillance is complicated 339 
by several factors including the timeliness of the data collected, quality and quantity of 340 
data, and most importantly, underreporting. Another complication of foodborne illness 341 
surveillance is that many pathogens transmitted through food also can be transmitted 342 
through water or from person-to-person contact. Thus, the role of food as vehicle for 343 
illness may be obscured. Interestingly, pathogens or agents that have not yet been 344 
identified, and cannot therefore be diagnosed, cause some proportion of foodborne 345 
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illness (30). Milder cases of foodborne illness are not often detected through routine 346 
surveillance; however, severe or even fatal cases are more likely detected. To survey 347 
foodborne illness, patients must go to a doctor’s office, have a sample tested and 348 
confirmed to be diagnosed. Not all foodborne illnesses cause severe symptoms, some 349 
may cause digestive upset, diarrhea, fever, and vomiting, and a person may not go to a 350 
doctor’s office to have a sample tested. If a person has a severe illness, or an illness 351 
causing death, a sample is more likely to be tested and confirmed to determine if there is 352 
a foodborne pathogen responsible for the illness or death. A highlight from the report is 353 
that E. coli infections continue to inch up and the progress noted from previous years has 354 
stalled, which is still about thirty percent lower than the FoodNet baseline year of 1996- 355 
1998 (14).  356 
In 1992, an outbreak of foodborne illness in several western states illustrated the 357 
seriousness of meat and poultry as important vehicles of pathogens associated with 358 
foodborne illness. The outbreak was attributed to undercooked hamburgers contaminated 359 
with E. coli O157:H7 that were served at a fast food chain restaurant, which caused 360 
several illnesses and four deaths. E. coli was described as a human pathogen in 1982, 361 
and this organism causes bloody diarrhea and hemolytic uremic syndrome (HUS) in 362 
some cases (28). Cattle are common reservoirs of the organism, and therefore beef and 363 
beef products are a potential mode of infection.  364 
Cattle are considered to be a definitive source of E. coli O157:H7, and through 365 
possible contamination of the carcass surface, a pathogen that may cause foodborne 366 
illness. In the U.S., individual animal prevalence is low and transient, but the natural 367 
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presence illustrates the complex relationship between the animal and its environment. 368 
Factors that may impact the animal and its’ environment include weather, and livestock 369 
production practices. For example, it has been shown that the problem of E. coli 370 
O157:H7 increases during the summer and fall months, but the environmental factor that 371 
impacts this is unknown. Livestock production practices may include feed, and waste 372 
handling practices, along with insects and microbial interactions between the soil and 373 
water (32).  374 
Outbreaks of illness caused by STECs are related to contact with animals and 375 
consumption of meat and fresh produce (26). Shiga toxin-producing E. coli can cause 376 
devastating illness, particularly in children, causing HUS leading to kidney failure. E. 377 
coli O157:H7 is the most notorious of the STEC strains causing approximately 73,500 378 
cases in the U.S. each year (26). The CDC estimates that non-O157:H7 STECs are 379 
responsible for about 37,000 cases of illness annually, but relatively fewer cases of 380 
virulent than E. coli O157:H7, a 2008 outbreak of STEC strain O111 in Oklahoma 381 
caused illness in at least 314 people, HUS in 17 cases, and one death (31), and other 382 
non-O157 outbreaks in the U.S. have been traced to contaminated lake water, salad 383 
greens, and milk (26). 384 
Most foodborne illnesses can be prevented, but continued efforts are needed to 385 
understand how contamination occurs to develop and implement measures to reduce it in 386 
meat and meat products (14). The nature of food and foodborne illness has drastically 387 
changed in the U.S. over the last century. Even with improved technology such as 388 
pasteurization and proper canning to eliminate some diseases, new causes of foodborne 389 
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illness continue to be identified (30). The CDC is working with state health departments 390 
to develop and implement ways to detect and investigate outbreaks more quickly so that 391 
the foods that cause outbreaks are identified and illnesses can be prevented (14). 392 
Enhanced measures are needed to control or eliminate pathogens in domestic and 393 
imported food, reduce or prevent contamination of food during growing, harvesting, and 394 
processing, and to continue the education of all food-handlers, including restaurant 395 
workers and consumers, about risks and prevention measures (14).   396 
Non-O157:H7 Shiga toxin-producing Escherichia coli 397 
The CDC estimates that about one third of the STEC infections in the U.S. are 398 
caused by non-O157:H7 serotypes; however, due to the challenge in identifying the non- 399 
O157 strains, this may be an underestimate (26). Many laboratories do not routinely 400 
screen for the shiga toxins, and may only attempt to isolate pathogens in the case of 401 
bloody diarrhea, or suspected outbreak (26). Non-O157 STEC are generally associated 402 
with a less severe illness that E. coli O157:H7; however, this may change due to bacteria 403 
that are readily available to exchange genetic material, and are constantly gaining or 404 
losing genetic information such as virulence factors (26). Non-O157 STEC infections 405 
can cause stomach cramps, diarrhea (sometimes bloody), and vomiting. If a fever is 406 
present, it is usually not very high and patients are better within 5-7 days. E. coli 407 
O157:H7 infections can cause bloody diarrhea, hemolytic uremic syndrome (HUS), 408 
thrombotic thrombocytopenic purpura (TTP), and death. The symptoms of non-O157 409 
STEC infections may be less severe than E. coli O157:H7 infections, but the ability of a 410 
bacterium to exchange genetic material, such as a virulence factor, may lend itself to the 411 
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non-O157 STEC infections potentially causing as severe foodborne illness as E. coli 412 
O157:H7. If the non-O157 STECs exchange genetic material with E. coli O157:H7 413 
foodborne illnesses may become more severe and may lead to cause more deaths.  414 
Numerous E. coli strains are capable of producing one or both Shiga toxins (stx1 415 
and stx2) (26). The STEC strains have been divided into five seropathotypes:  416 
• A: including the O157 strains that are common causes of outbreaks and 417 
HUS in most countries;  418 
• B: non-O157 strains that cause occasional outbreaks, but are fairly 419 
common isolates from sporadic cases and HUS (O26:H11, O103:H2, 420 
O111:NM, O121:H19, O145:NM);  421 
• C: non-O157 strains associated only with sporadic cases;  422 
• D: strains associated with diarrhea, not more severe symptoms; and E, 423 
strains not associated with human disease (21, 25).  424 
From outbreaks and sporadic cases of HUS and severe diarrhea, more than two hundred 425 
virulent non-O157 serotypes have been isolated in the U.S. and other countries. Among 426 
the most frequently detected serogroups are O111, O103, and O26 (4). Because the 427 
standard stool culture methods routinely used in many clinical laboratories do not detect 428 
these bacteria, the true incidence of non-O157 STEC infections is more than likely 429 
underestimated.  430 
Non-O157 STEC serotypes as with E. coli O157:H7, are often associated with 431 
cattle and other ruminants, as part of the natural gut micro flora. Cattle can often harbor 432 
multiple serotypes, some with which lack the virulence factors, and are therefore less of 433 
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a health risk. Microbes can; however, readily exchange genetic information, and the 434 
presence of any STEC in food production environments is of concern (26). To minimize 435 
human infections with non-O157 STEC, it is necessary to understand which serotypes 436 
are most virulent, and the ways in which people are exposed to these pathogens. The 437 
epidemiology of infections caused by non-O157 STEC serotypes, with a more 438 
comprehensive understanding will lead to improved control methods to prevent illness 439 
and reduce economic loss to both food producers and processors.  440 
Beef cattle slaughter operations and possible microbial contamination 441 
Beef can be contaminated during slaughter and processing by exposure to feces 442 
or hides containing non-O157 STEC (26). E. coli O157:H7 and non-O157:H7 STECs 443 
are a naturally occurring part of the gut microflora in cattle. During the slaughter 444 
process, close attention must be paid in order to avoid the contamination of what is 445 
otherwise sterile meat. Feces, ingesta, and milk are common vehicles for the transfer of 446 
pathogens to the meat. Beginning in the beef slaughter process, the use of dirty knives, 447 
dirty equipment, unsanitary conditions, and poor employee training must be avoided. 448 
The hide removal process must be done to ensure that feces or dirt containing feces does 449 
not drop back onto the carcass. During the evisceration process, it is important that the 450 
gut not be too full, in which case it may break, causing ingesta to come in contact with 451 
the carcass. If feces, ingesta, or milk come in contact with the carcass surface, potential 452 
pathogens may contaminate the meat or meat product further in the processing. A visual 453 
inspection of the carcass is completed to check for any signs of feces, milk or ingesta on 454 
the carcass. If any of the items are found, they must be trimmed away from the carcass. 455 
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The interior most portion of the muscle is considered sterile, so it is valuable to the food 456 
production process that no pathogens come in contact with the carcass that will 457 
eventually be broken down into subprimal, retail, and further processed products. 458 
Through the process of breaking down subprimals, any potential pathogen that may have 459 
been present on the exterior portion of the meat, may be transferred to the interior 460 
portion of the meat. Whether through a knife cut, blade-tenderization machine, or a 461 
vacuum tumble marinade, further processing meat and meat products could potentially 462 
contaminate all exterior and interior surfaces of the end product that is purchased by the 463 
consumer. The consumer has the responsibility of properly cooking, cooling, and 464 
preventing cross contamination of the product at home.  465 
Hazard Analysis and Critical Control Point System (HACCP) in the beef slaughter 466 
process 467 
HACCP is a preventive system that enables the production of safe meat and meat 468 
products, and provides the necessary tools to prove the product has been produced 469 
safely. There are seven principles within a HACCP system. Before beginning a HACCP 470 
plan, a production process must develop and identify pre-requisite programs, good 471 
manufacturing practices, and sanitation standard operating procedures. These items 472 
provide the necessary tools and background to maintain facilities, good employee 473 
hygiene, and proper and efficient cleaning procedures. The first step in a HACCP plan is 474 
to conduct a hazard analysis to identify any potential physical, chemical, or biological 475 
hazards that may be reasonably likely to occur (23). Of the three different types of 476 
hazards that are reasonably likely to occur within a processing facility, biological, 477 
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chemical, or physical, a biological hazard is the hazard that impacts the most consumers. 478 
If a consumer finds a piece of plastic in their food, they are impacted by the hazard, but 479 
more often than not, it may simply be one consumer. If there is a product that has tested 480 
positive for E. coli O157:H7, that product may reach more consumers, and have a 481 
greater economical impact. With the characteristics of E. coli, elderly and young 482 
consumers have the highest risk of foodborne illness, should the adulterated product be 483 
consumed. The second step in a HACCP plan is to determine critical control points 484 
(CCPs), which are points in a process that may reduce or eliminate any potential hazard. 485 
Examples of CCPs may include a metal detector, cooking, cooling, or the use of an 486 
intervention such as an antimicrobial spray. After the CCPs have been identified, critical 487 
limits must be set. Critical limits may be a time or temperature, or the time/temperature 488 
relationship. The CCPs and critical limits have to be monitored to assure they are being 489 
met, which is the fourth step in a HACCP plan. The fifth step in a HACCP plan is to 490 
establish corrective actions, or determine what has to be done if a CCP is not met. The 491 
product may need to be rendered inedible, re-heated, re-sprayed, and the reason for the 492 
deviation must be identified and eliminated in the future. The sixth and seventh steps of 493 
a HACCP system include verification and record-keeping documentation and 494 
procedures. Verification must be done to assure that CCPs are working to control, 495 
reduce, or eliminate potential pathogens, and all records must be kept to be able to prove 496 
safe production of meat and meat products. In a HACCP system, with it being 497 
preventive, producers try to eliminate the E. coli before it may have a chance to 498 
contaminate a carcass.  499 
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Different antimicrobial interventions have been utilized as CCPs at different 500 
points in the slaughter and further processing processes to reduce or minimize meat 501 
contamination causing foodborne illness. During the slaughter process, bacterial 502 
contamination can be carried over from previous slaughter steps. The purpose of a CCP 503 
in the slaughter process is to prevent, remove, or reduce the bacterial contaminants. 504 
Physical or chemical procedures, such as antimicrobial interventions, reduce the 505 
pathogen load on the carcass surface.  506 
Pathogen reduction on beef carcasses and intervention steps 507 
Interventions may be used to reduce or eliminate the presence or growth of 508 
potential pathogens on the carcass. Most commonly, interventions are applied in the 509 
form of spraying; however, there are many intervention options beginning with pre- 510 
harvest interventions, processing interventions, and environmental interventions. Pre- 511 
harvest interventions may include dietary treatments such as feed, probiotics, 512 
bacteriophages, chlorate, drinking water, and vaccines.  513 
Feeding a high-grain ration to feedlot cattle may cause starch from the grains to 514 
escape fermentation in the rumen, and pass to the hindgut affecting the survival of some 515 
bacteria. Bacteria that are naturally occurring in the intestinal tract of cattle include E. 516 
coli O157:H7 and non-O157 STECs, and if they survive, they may be more likely to 517 
contaminate carcass surfaces and cause foodborne illness if not properly eliminated. The 518 
addition of probiotics to feed has been suggested to prevent the growth of STEC in the 519 
ruminant of young animals. Probiotics may include live bacteria and yeasts that are 520 
healthy for gut production, and may, in a young animal, increase the effective bacteria, 521 
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and help to decrease the adverse bacteria. Concurrent with probiotic use is the use of 522 
bacteriophages, which are viruses that can kill bacteria. A bacteriophage can enter the 523 
bacteria, infect and replicate, and may decrease the incidence of non-O157 STECs. E. 524 
coli can metabolize chlorate, a toxic compound. Feeding chlorate to cattle, either in the 525 
feed or water, can significantly reduce the concentration of E. coli O157:H7 and other E. 526 
coli in feces (1). If the organisms are reduced in the feces, feces that may contaminate 527 
the carcass surface through the slaughter process may be less likely to contain E. coli 528 
O157:H7 or non-O157 STECs. Drinking water can also be a source of STEC infection in 529 
cattle if it is contaminated with fecal matter. Chemical treatments may be added to the 530 
water, such as lactic acid or acidified calcium sulfate; however, the cattle may drink less 531 
water due to the taste of the chemicals, which is why they should not be used 532 
continuously.  533 
One last pre-harvest intervention is the use of vaccines. Vaccines have 534 
proprietary considerations, and little information is often available, but if the vaccine is 535 
proven effective in cattle, it may offer protection against non-O157 strains if they induce 536 
antibodies to a common virulence factor (26). Pre-harvest interventions are important 537 
because they may be useful in reducing the potential pathogens from entering the 538 
processing facility through fecal matter or ingesta.  539 
The environment in which interventions are applied plays an important role in 540 
the effectiveness of the intervention to successfully reduce or eliminate potential 541 
pathogens. For example, the addition of a chemical to water in a feed trough may reduce 542 
the amount of water an animal drinks. Processing interventions involve the carcass 543 
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surfaces, and further processing of the carcass into subprimals, steaks, ground beef, or 544 
sausage for example. From the live animal to the steak on the grill, interventions are 545 
applied at many levels to produce a safe product.  546 
Interventions applied during the processing of beef carcasses 547 
Acid interventions are often applied to beef as antimicrobial treatments. The use 548 
of antimicrobial treatments lowers the carcass surface pH. L-lactic, acetic and 549 
peroxyacetic acids, acidified sodium chlorite and aqueous ozone solutions have 550 
demonstrated some reduction of the microbial populations on hot and chilled beef 551 
carcasses (2, 10, 13, 15). L-lactic acid is one of the most effective and cost-efficient 552 
treatments for reducing microorganisms on the carcass surface. For this reason, in this 553 
study, L-lactic acid was used to acidify the PBS that was used to determine acid 554 
resistance of E. coli biotype I surrogates, and non-O157 STECs.  555 
The efficacy of L-lactic acid can be increased when applied at 55°C, and when 556 
used in combination with other interventions such as a hot water wash (10, 12, 17). The 557 
temperature at which lactic acid has an increased efficiency, 55°C, was one of the 558 
temperatures that was evaluated in this study. Two other temperatures above 55°C, 559 
(60°C and 65°C), were also evaluated to determine the resistance to heat of the E. coli 560 
biotype I surrogates and the non-O157 STECs in this study. Resistance to acid and heat 561 
are integral in determining the usefulness of an antimicrobial to reduce or eliminate 562 
potential pathogens.  563 
Lactic acid has been demonstrated to effectively reduce E. coli O157:H7 and 564 
Salmonella populations on the surface of beef carcasses (9, 11, 12, 16, 20, 34). E. coli 565 
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biotype I surrogate organisms have been shown to represent E. coli O157:H7 and 566 
Salmonella. To test the usefulness of these surrogate organisms for these pathogens, 567 
resistance to acid and heat were determined. It is important to test the resistance of acid 568 
and heat as it relates directly back to the use of antimicrobial interventions. Due to the 569 
increase in foodborne illness infections caused by non-O157 STECs, there is a need in 570 
the beef industry to determine potential surrogates for these organisms. Potential 571 
surrogates that have the same resistance to acid and heat as the non-O157 STECs could 572 
potentially be used to validate the effectiveness of a processing facilities’ antimicrobial 573 
interventions, and their ability to reduce or eliminate potential pathogens that may cause 574 
foodborne illness.  575 
The use of indicator and surrogate microorganisms 576 
When evaluating the quality or safety of raw or processed food products and 577 
validating the effectiveness of microbial control measures, indicator or surrogate 578 
microorganisms are often used (7). Indicator use is highly dependent upon the 579 
microbiological criteria that are set forth in the food product, and frequently used on an 580 
informal basis with a specified company. The use of indicator and surrogate 581 
microorganisms require specific attention to detail, including the specific food item, 582 
harvesting area, and other growth environmental conditions. It is important when 583 
choosing a surrogate or indicator microorganism to select the most significant microbial 584 
contaminant of concern, and the analytical methods to detect or enumerate the organism 585 
are also important (7). Due to processing or microbial reduction treatments, special 586 
methods are needed to retrieve the indicator or surrogate or their metabolic or genetic 587 
  16 
component if injured survivors or systems are in place to enumerate accurately (7). A 588 
sampling plan that will assure statistically significant findings is an essential element to 589 
microbiological monitoring. Also to consider when choosing the appropriate surrogate or 590 
indicator microorganism is a scheduled review of the criteria for the surrogate or 591 
indicator to determine if they continue to be appropriate under the conditions are being 592 
evaluated (7).  593 
To be considered for use as an ideal surrogate, the organism would be a 594 
nonvirulent strain of the target or test pathogen. Ideally, the surrogate would carry all 595 
characteristics of the target pathogen except pathogenicity (7). A surrogate organism 596 
may not be selected for use due to the possibility that the strain may return to 597 
pathogenicity. Another reason a surrogate may not be selected would be due to the 598 
possibility of detection leading to a false positive during routine testing. A false positive 599 
indicates a positive when in fact it is negative. For example if a test showed E. coli 600 
O157:H7 positive, but the sample did not in fact carry E. coli O157:H7. In the food 601 
industry, several issues may arise should a sample be deemed positive when in fact it is 602 
not. A surrogate is ideally picked out of a population of well-known organisms with a 603 
well-defined characteristic of being nonpathogenic. The most ideal characteristics of a 604 
surrogate are nonpathogenic, isolated from the same environment as the target pathogen, 605 
correlating in populations, and similar in growth characteristics, including population 606 
densities. Surrogate organisms must respond to processing parameters, such as 607 
antimicrobial interventions, in the same manner as the target pathogen (7). Previously 608 
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published data have identified surrogate organisms that represent E. coli O157:H7 and 609 
Salmonella, whereas in this study the target pathogens were the non-O157 STECs.  610 
Marshall et al. (29) sampled the hides of twenty beef cattle, obtaining 113 611 
bacterial isolates. Growth and biochemical characteristics were evaluated, and thirteen of 612 
the isolates were selected for being similar to five clinical strains of E. coli O157:H7. D- 613 
values at 65°C for the thirteen isolates were not different from E. coli O157:H7 strains 614 
(29). Pre-rigor lean and adipose tissue from beef carcasses were contaminated with a 615 
fecal inoculum (either five E. coli beef cattle isolates or a cocktail of five E. coli 616 
O157:H7 strains), and processed with antimicrobial interventions. Depending on the 617 
antimicrobial used (water, lactic acid, chlorine or trisodium phosphate), the 618 
appropriateness of the isolates for E. coli O157:H7 varied, but the mean log reductions 619 
of at least two E. coli isolates were not different (P > 0.05) from the mean log reduction 620 
of the E. coli O157:H7 cocktail (29). Marshall et al. (29) demonstrated the use of 621 
potential surrogates that were isolated from the same environment as the target pathogen 622 
(beef cattle hides), and were shown to have similar characteristics (D-values), and 623 
effectiveness with antimicrobial interventions.  624 
Cabrera-Diaz et al. (8) evaluated the effectiveness of the E. coli biotype I strains 625 
identified and isolated from cattle hides (previously discussed) to E. coli O157:H7 and 626 
Salmonella. In a collaborative study with Texas A&M University and Iowa State 627 
University, the potential surrogates were sent to the E. coli Reference Center at Penn 628 
State University, and tested negative for virulence attributes, and were considered 629 
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nonpathogenic. For beef processing, and use in a validation study, a nonpathogenic 630 
organism is key in assuring no potential contamination for the product or environment.  631 
Throughout the beef industry, many antimicrobial interventions are used 632 
individually, in combination with water, steam or pressure, and in combination with 633 
other antimicrobial interventions. Due to variation among organisms, no one single 634 
organism, or isolate can realistically represent the possible effectiveness of all microbial 635 
interventions that may be used in a beef processing facility to reduce or eliminate 636 
potential pathogens. The combination of organisms may be required to adequately 637 
predict the effectiveness of microbial interventions that may be used in beef processing 638 
facilities and their effectiveness against E. coli O157:H7 or the non-O157 STECs.  639 
To reduce enteric pathogens on beef carcasses, the efficacy of antimicrobial 640 
interventions implemented at the slaughter establishment must be validated under the 641 
commercial operating conditions. Surrogate organisms that are non-pathogenic present 642 
an ultimate opportunity to validate beef carcass interventions without the use of the 643 
enteric pathogen in the commercial facility. Cabrera-Diaz et al. (8) evaluated the 644 
appropriateness of E. coli biotype I surrogates to E. coli O157:H7 and Salmonella using 645 
growth curves, acid and thermal resistance, cell surface hydrophobicity, attachment to 646 
beef carcass surfaces and response to antimicrobial interventions on beef carcasses.  647 
The process of identifying appropriate surrogate microorganisms for pathogenic 648 
organisms is demonstrated by first selecting the organisms from the appropriate 649 
environmental conditions, secondly, determining the characteristics of the organisms at a 650 
laboratory level; such as growth parameters, resistance to acid and thermal, and 651 
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resistance to freezing and refrigerated storage, and lastly, by conducting research using 652 
beef carcass surfaces, antimicrobial interventions and processing techniques. Organisms 653 
that best represent pathogenic strains have similar characteristics and perform similarly 654 
under processing conditions. Cabrera-Diaz et al. (8) found that growth parameters: 655 
growth rate, doubling time, maximum population density, and lag time, were not 656 
different among the potential surrogates and target pathogens (P > 0.05). The E. coli 657 
biotype I surrogates had similar acid resistance at pH 3.0, 4.0 and 5.0, and similar 658 
thermal resistance at 55 and 65°C when compared to the pathogenic E. coli O157:H7 659 
strains (8, 28). Following evaluation of the surrogate organisms in a laboratory setting, 660 
to be used efficiently as a surrogate, the exact processing conditions must be replicated. 661 
There are many factors that are involved in the processing of meat and meat products 662 
including the attachment of the organism to the carcass surface, and response to 663 
antimicrobial interventions.  664 
Cabrera-Diaz et al. (8) evaluated cell surface hydrophobicity which is an 665 
attractive force that is correlated to microbial adhesion to surfaces, more specifically, 666 
carcass surfaces. This trait would be important in determining the ability of organisms to 667 
adhere to a beef carcass surface. Cell surface hydrophobicity was different (P < 0.05) 668 
among surrogates and some E. coli O157:H7 strains, but the strength of attachment to 669 
beef carcasses was not different (P > 0.05) among all of the organisms (8).  670 
Attachment to beef carcass surfaces is important in determining the efficacy of 671 
antimicrobial interventions. Bacterial cells may be loosely or strongly attached to a beef 672 
carcass surface, which may include muscle, fat, bone, and other tissue matter. A loosely 673 
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attached bacterial cell is freely located within the water film on the surface of tissues, 674 
and a strongly attached bacterial cell can be physically associated with the tissue surface. 675 
In this study, the numbers of loosely and strongly attached bacterial cells on the surfaces 676 
of hot-boned-outside rounds, briskets and clods were compared between the fluorescent 677 
protein-marked surrogate, E. coli O157:H7, and Salmonella strains (8). Mean counts of 678 
loosely attached cells were not different (P > 0.05) among surrogate, E. coli O157:H7 679 
and Salmonella strains (regardless of carcass region), and strongly attached cells were 680 
not different (P > 0.05) between surrogates and target pathogens on the same carcass 681 
region (8). Differences (P < 0.05) were noted for the strongly attached cells of 682 
Salmonella on the outside round when compared with attached cells of the surrogates 683 
and E. coli O157:H7 strains on the clod. These differences may be related to carcass 684 
topography, which is important in determining the differences in bacterial attachment. 685 
When conducting research to determine the strength of bacterial attachment, it is 686 
important to note and maintain consistency in the use of carcass topography to eliminate 687 
the variable as a possible reason for variation among organisms and method of 688 
attachment.  689 
The process of inoculating beef carcass surfaces for the purpose of research may 690 
impact the results of the study. For example, it is more difficult to remove E. coli 691 
O157:H7 from a beef carcass surface when inoculated with bovine feces rather than a 692 
buffered solution. Dickson and Koohmaraie (18) failed to find a correlation between the 693 
cell surface hydrophobicity and attachment on lean beef tissue, which supports other 694 
research demonstrating a lack of correlation between cell surface hydrophobicity and 695 
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attachment between Salmonella Choleraesuis to either fat or lean beef (3). Rivas et al. 696 
(33) demonstrated a lack of correlation between the cell surface hydrophobicity of Shiga 697 
toxin-producing E. coli strains and their adhesion. The lack of correlation between cell 698 
surface hydrophobicity and attachment has been demonstrated by previously published 699 
research and can be attributed to the complexity and heterogeneous nature of the beef 700 
carcass surface, or more importantly, meat surface tissues.  701 
Hot water washes and 2% L-lactic acid sprays were applied to beef carcass 702 
surfaces to demonstrate the response of fluorescent protein-marked surrogates, E. coli 703 
O157:H7 and Salmonella strains. Log reductions (CFU per square centimeter) after 704 
application of the treatments were not different (P > 0.05) among the surrogates, E. coli 705 
O157:H7 and Salmonella strains (8).  706 
Ingham et al. (24) conducted a study to compare the survival of potential 707 
pathogen surrogates with the survival of E. coli O157:H7. The surrogates used in this 708 
study were meat hygiene indicators (non-E. coli coliforms, biotype I E. coli, and lactic 709 
acid started cultures). The study was conducted to evaluate interventions using beef 710 
brisket (adipose and lean), cod fat membrane, or neck tissue. Treatments were grouped 711 
by abattoir size and may have included a dry-aging period, acidic antimicrobial 712 
intervention, or hot water treatment. These data demonstrated that all three-surrogate 713 
inocula (non-E. coli coliforms, biotype I E. coli, and lactic acid bacteria) represented E. 714 
coli O157:H7 for dry-aging and acid-spray plus dry-aging treatment used by small 715 
abattoirs (24). In large abattoirs, no one inoculum was suitable for E. coli O157:H7 716 
across the intervention treatments used, but the effects seen on neck tissue were 717 
  22 
representative of other tissues, and the low value on the neck supports its use as the 718 
location for evaluating the treatment efficacy in in-plant trials (24).  719 
Keeling et al. (28) demonstrated further research into the evaluation of the 720 
previously identified E. coli biotype I strains as surrogates (29) for E. coli O157:H7. 721 
Meat processing conditions, outside of the harvesting of the animal, further impact the 722 
presence or growth of potential pathogens on the beef carcass surface or meat tissue. 723 
Four meat processes that may reduce bacterial load (cooking, fermenting, refrigerating 724 
and freezing) were conducted to compare the biotype I surrogate strains with E. coli 725 
O157:H7.  726 
Throughout the duration of the study (28), with all four processes, at least one of 727 
the surrogate organisms was not statistically different when compared to E. coli 728 
O157:H7. This study demonstrated no differences (P > 0.10) between isolates BAA- 729 
1428, BAA-1430 and E. coli O157:H7 during the frozen shelf life study. The remaining 730 
three surrogates that were evaluated survived better during the frozen shelf life study 731 
indicating a level of safety representing E. coli O157:H7. Throughout the evaluation at 732 
refrigerated temperatures, none of the E. coli biotype I surrogates were statistically 733 
different (P > 0.10) when compared to E. coli O157:H7. Variations did exist between the 734 
organisms over time; however, none of the surrogate strains showed statistically lower 735 
populations that E. coli O157:H7. In the fermentation study, all of the surrogates, with 736 
the exception of BAA-1428 had smaller reductions in populations when compared to E. 737 
coli O157:H7, which may prove valuable in over predicting the reduction in or survival 738 
of E. coli O157:H7 during fermentation. BAA-1427 was the only isolate during 739 
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fermentation that was not statistically different (P > 0.10) from E. coli O157:H7. In 740 
evaluating all of the processes demonstrated in this study, isolates BAA-1427, BAA- 741 
1429 and BAA 1430 would be good surrogates for E. coli O157:H7. In the thermal 742 
activation study, these isolates resulted in smaller population reductions that E. coli 743 
O157:H7. Smaller population reductions may indicate that the surrogate organisms may 744 
over predict the population of E. coli O157:H7 in these processing conditions.  745 
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3. MATERIALS AND METHODS 746 
 747 
Bacterial cultures 748 
The biochemical profiles of E. coli biotype I surrogates and non-O157 STECs 749 
were determined using the Vitek 2, Compact 15 system (bioMèrieux, Inc., Durham, NC) 750 
to determine the identification of E. coli. The biotype I surrogate isolates have been 751 
deposited with the ATCC (Manassas, VA) under accession numbers BAA-1427, BAA- 752 
1428, BAA-1429, BAA-1430, and BAA-1431. The non-O157 STEC isolates that were 753 
used were under ATCC accession numbers BAA-2192 (O145:NM), BAA-2193 754 
(O45:H2), BAA-2196 (O26:H11), BAA-2215 (O103:H11), BAA-2217 (O111) 755 
(organism was originally ordered from American Type Culture Collection (ATCC) 756 
under accession # BAA-2217, and has since then been reclassified as O147, see 757 
Appendix), and BAA-2219 (O121:H19). Rif-resistant organisms were derived from each 758 
E. coli biotype I surrogate. Rif-resistant organisms were isolated, following the method 759 
described by Kaspar and Tamplin (27), by spread plating 1.0 ml of a suspension 760 
containing approximately 108 CFU/ml on tryptic soy agar (TSA, Becton Dickinson, 761 
Sparks, MD) containing 0.1 g of rifampicin (Sigma Aldrich Life Science, St. Louis, MO) 762 
dissolved in 5 ml of methanol per liter (L). Rifampicin was added following the 763 
autoclaving and tempering (approximately 50°C). Inoculated plates were incubated at 764 
37°C for 24 h, and several of the resulting colonies were streaked on rif-TSA plates. The 765 
strains were streaked on consecutive days on rif-TSA to ensure rif-resistance (27). Stock 766 
working cultures were prepared on TSA. 767 
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Growth parameters 768 
Growth characteristics were compared to determine if the surrogates could be 769 
used to represent non-E. coli O157 STECs. Each strain (E. coli biotype I surrogates, rif- 770 
resistant E. coli biotype I surrogates, and non-O157 STECs) was cultured individually in 771 
tryptic soy broth (TSB, Becton Dickinson) at 37°C for 18 h. Rif-resistant surrogates 772 
were used in comparison against the parent strain. Following incubation, 0.1 ml of the 773 
approximate 108 CFU/ml culture was transferred to 9 ml of 0.1% peptone water (PW, 774 
Becton Dickinson) to dilute the culture, and subsequent serial dilutions were made in 775 
0.1% PW for each culture until approximately 5 log CFU/ml. After each final culture 776 
was diluted, 0.1 ml was transferred into a fresh tube containing 10 ml TSB. All tubes 777 
were incubated at 37°C in a constant temperature water bath (VWR International 778 
(89032-220), Radnor, PA) and over a 24-h period, one tube from each strain was 779 
removed at 0, 1, 2, 3, 6, 7, 8, 10, 12, and 24 h for enumeration. Appropriate decimal 780 
dilutions in 0.1% PW were plated on TSA and rif-TSA using the Whitley Automatic 781 
Spiral Plater (WASP) (Model #S00600, Microbiology International, Frederick, MD). 782 
Plates were incubated (Gravity Convection Incubator E191047, VWR International) at 783 
37°C for 24 h before determining counts. Plates were counted using the grid provided by 784 
DW Scientific, and two opposite quadrants were determined and counted. After a count 785 
was achieved, the count was converted to scientific notation using the conversion chart 786 
provided by DW Scientific and after accounting for the appropriate decimal dilutions, a 787 
final log count was achieved. Each growth curve was completed in three replications. 788 
The General Linear Model (GLM) of SAS (SAS Institute, Inc., Cary, NC) was used for 789 
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data analysis. Least squares means were calculated and used to compare growth 790 
characteristics of the parent and rif-resistant E. coli biotype I surrogates, and non-O157 791 
STECs, both as individual strains, and sets of strains (parent and rif-resistant E. coli 792 
biotype I strains, and non-O157 STECs). Sets of strains were analyzed to eliminate 793 
individual strain-to-strain variation and represent what may occur should organisms be 794 
used as a cocktail.  795 
Acid resistance 796 
Throughout the process of harvesting beef cattle, antimicrobial interventions are 797 
often applied to reduce the pH of the carcass surface, further reducing or eliminating 798 
potential pathogens. Each individual strain was cultured in TSB at 37°C for 18 h. 0.1 ml 799 
aliquots of the fresh cultures were then transferred to 10 ml TSB and 10 ml TSB+G 800 
tubes (supplemented with 1% glucose (10 ml glucose/1L of TSB), (D-Glucose, 801 
Anhydrous, Granular, Macron Fine Chemicals, Center Valley, PA), to induce an acid 802 
tolerance response). Buchannan and Edelson (5) demonstrated that prior growth of an 803 
organism in a medium with a fermentable carbohydrate (TSB+G) induces an acid- 804 
tolerance response. Following incubation at 37°C for 18 h in either TSB or TSB+G, each 805 
culture was transferred to a 15 ml conical centrifuge tube (#89039-666, VWR 806 
International). The cultures were then harvested using a Heraeus Megafuge 16 807 
Centrifuge (Thermo Fisher Scientific, Waltham, MA) at 1,620 × g for 15 min. After the 808 
cultures were centrifuged, the supernatant was poured off and the pellet re-suspended in 809 
10 ml phosphate buffered saline (PBS, EMP Chemical Inc., San Diego, CA). The pH of 810 
the PBS was taken each time it was prepared and found to be approximately 7.4. 811 
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Following re-suspension of the pellet in 10 ml PBS, the cultures were centrifuged again 812 
(1,620 × g for 15 min), and the procedure repeated an additional two times, for a total of 813 
four centrifugation cycles. After the final pellets were re-suspended in 10 ml PBS, 0.1 ml 814 
aliquots were transferred into glass tubes (16 × 150 mm) containing 10 ml pre-warmed 815 
(37°C) PBS acidified with 88% L-lactic acid (Purac, Lenexa, KS). Three different pH 816 
values were evaluated in this experiment, pH 2.5, 3.0, and 3.5. All tubes were incubated 817 
in a constant temperature water bath (37°C), with the water level at least 1 cm above the 818 
level of the suspension. Immediately after inoculation of the acidified PBS with the 819 
culture, one tube was removed for enumeration of survivors. The remaining tubes 820 
remained in the constant temperature water bath and were removed (one tube of each 821 
strain) at 0.5, 1.0, 1.5, and 2.0 h for enumeration of survivors. Survivors were serially 822 
diluted using 0.1% PW and using the WASP, plated on TSA or rif-TSA. Plates were 823 
incubated at 37°C for 24 h and survivors were counted using the method as previously 824 
described above. Each experiment was conducted in three replications, and log 825 
reductions (CFU/ml) were calculated by subtracting the log count (CFU/ml) of each 826 
strain after each exposure time (0.5, 1.0, 1.5, and 2.0 h) from the initial log count 827 
calculated following the initial inoculation. The GLM of SAS was used to calculate least 828 
squares means to determine significant differences between the individual strains, and 829 
sets of parent and rif-resistant E. coli biotype I surrogates, and the non-O157 STECs. 830 
 831 
 832 
 833 
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Thermal resistance 834 
In order to determine and compare the decimal reduction time (D-value) or the 835 
time required at a given temperature to kill 90% of the exposed microorganisms, thermal 836 
resistance of the parent and rif-resistant E. coli biotype I surrogates, and the non-O157 837 
STECs were calculated at three different temperatures. After calculating D-values, z- 838 
values were also calculated by plotting the log10 of the D-values across temperature. Z- 839 
values are calculated to determine the relative resistance of an organism to different 840 
temperatures, and to show the degrees (F or C) required for the thermal destruction curve 841 
to traverse 1 log cycle (the change in temperature that changes the D-value by a factor of 842 
10).  843 
Individual strains were cultured in TSB at 37°C for 18 h. Aliquots of 0.1 ml of 844 
each culture were transferred to individual 10 ml TSB and 10 ml TSB+G tubes for a 845 
second incubation at 37°C for 18 h. TSB+G was used in this experiment to determine if 846 
there was a cross-adaptation between acid-adapted organisms and temperature. For 847 
centrifugation, each culture was transferred to a 15 ml conical centrifuge tube, and 848 
harvested at 1,620 × g for 15 min. After centrifugation, the supernatant was poured off, 849 
and the pellet was re-suspended in 10 ml PBS. The pH of the PBS was 7.4. The cell 850 
suspension was centrifuged again, and the procedure of pouring of the supernatant and 851 
re-suspending the pellet in 10 ml PBS was followed. This procedure was performed two 852 
more times. The cells were washed 4 times. After the fourth and final re-suspension, 50 853 
µL of each individual culture were inoculated into a capillary tube (1.5-1.8 mm, 854 
Chemglass Life Science, Vineland, NJ.). The capillary tubes were flame sealed on each 855 
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end, and submerged in a beaker (400 ml), covered with a watch glass to maintain 856 
temperature and prevent possible contamination, in a constant temperature water bath at 857 
55, 60, and 65 ± 0.5°C. Depending on the temperature, pre-determined time intervals 858 
were calculated, and at each time point, one capillary tube of each strain was removed 859 
from the constant temperature water bath, dipped in pre-chilled 70% ethanol for 30 s, 860 
and rinsed in pre-chilled sterile water in an ice bath. Using sterile forceps, each capillary 861 
tube was then transferred to a conical centrifuge tube containing 10 ml PBS. The 862 
capillary tubes were crushed using a sterile glass rod. The suspension was serially 863 
diluted in 0.1% PW and plated using the WASP on TSA and rif-TSA. Enumeration was 864 
performed after incubation at 37°C for 24 h. Survivors were counted using the procedure 865 
previously described. Each experiment was conducted in three replications. Survivor 866 
data (log CFU/ml) was plotted as a function of time as a scatter plot (a mathematical 867 
diagram used to identify and display the type of relationship between two quantitative 868 
variables) in Microsoft Excel. Using at least three of the most linear points with the 869 
shallowest slope, a linear regression analysis was conducted to determine the slope of 870 
the line. At least three of the most linear points were used to predict the relationship 871 
between times and log value counts. D-values were calculated using the reciprocal of the 872 
calculated slope. After calculating the D-values, log D-values were calculated and 873 
plotted as a function of temperature as a scatter plot in Microsoft Excel. A linear 874 
regression analysis was conducted to determine the slope of the line, and the z-value was 875 
demonstrated by using the reciprocal of the calculated slope. The GLM of SAS was used 876 
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to determine least squares means to demonstrate significant differences between the 877 
parent and rif-resistant E. coli biotype I surrogates, and the non-O157 STECs.  878 
Response to refrigeration and freezing temperatures 879 
Throughout the processing of meat and meat products, items may be processed or 880 
stored in refrigeration or freezing temperatures. It is important to understand the 881 
organisms’ response to these temperatures, to represent a scenario where the organisms 882 
may be present on the meat or meat product. If the organism is present and stored at 883 
refrigeration or freezing temperature, the characteristics of the organism must be 884 
identified. In using cold storage as a Critical Control Point (CCP), it must be 885 
documented if the organism is present whether it will grow, or be reduced.  886 
To test the organism’s resistance to refrigerated and frozen storage, each 887 
individual strain was cultured in TSB at 37°C for 18 h. A second transfer was then made 888 
to either 10 ml TSB or 10 ml TSB+G and incubated at 37°C for 18 h. As in thermal 889 
resistance, acid-adapted cultures (TSB+G) were also used to test resistance to 890 
refrigeration and frozen storage to determine if there was a cross-adaptation to the cold 891 
temperatures with the cells. Each individual culture was then transferred to a 15 ml 892 
conical centrifuge tube, and centrifuged at 1,620 × g for 15 min. After centrifugation, the 893 
supernatant was poured off, and the pellet was re-suspended in 10 ml PBS (pH 7.4). 894 
After the pellet was re-suspended, the cells were centrifuged again, the supernatant was 895 
discarded, and the pellet was re-suspended in 10 ml PBS. This process was repeated for 896 
a total of four centrifugation cycles. The final pellet was re-suspended in 100 ml PBS, 897 
and 1 ml of the bacterial strains was transferred into individual 1.5 ml sterile Safe-lock 898 
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tubes (micro-centrifuge tubes, Safe-lock, Eppendorf, Hauppauge, NY). Fifty % of the 899 
tubes (n = 672) were stored at 4 ± 0.5°C (refrigeration) and the remaining 50% (n = 672) 900 
at -20 ± 0.5°C (freezing). Initially, and at 7, 14, 21, 28, 60, and 90 day of storage, one 901 
tube of each culture was removed from the refrigerated or frozen storage. Frozen 902 
cultures were defrosted in an ice water bath for approximately 30 min before 903 
enumeration. Enumeration was determined using the WASP on TSA and rif-TSA plates, 904 
following serial dilutions in 0.1% PW, and incubation at 37°C for 24 h. Survivors were 905 
counted using the grid (DW Scientific) and counting two opposite quadrants, converted 906 
to scientific notation after accounting for the serial dilutions and converted to a log 907 
count. Each experiment was conducted in three replications. Mean log counts were 908 
compared using the GLM of SAS to determine significant differences between the 909 
parent and rif-resistant E. coli biotype I surrogates, and the non-O157 STECs.  910 
 911 
 912 
  913 
 914 
 915 
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4. RESULTS AND DISCUSSION 916 
 917 
Growth parameters 918 
For the E. coli biotype I surrogate microorganisms to be useful in predicting the 919 
behavior of pathogens during processing, the growth of these surrogates would ideally 920 
be equivalent or slightly greater, but not less than that of the target pathogens (six non- 921 
O157 STECs) (7). The characteristics of a surrogate organism include having similar 922 
growth characteristics, including population densities. A surrogate organism would be 923 
equivalent or slightly greater in growth than the target pathogen to represent the greatest 924 
potential growth that may be achieved by the target pathogen. Growth curves of E. coli 925 
biotype I surrogates, both the parent strains and rif-resistant strains, were similar to those 926 
of all non-O157 STECs throughout the evaluation (Table 1), differing by 0.7 log or less 927 
at each 1-h evaluation during the 24-h growth period. There were differences between 928 
individual organisms (P < 0.05) throughout the evaluation, which supports previously 929 
published research (19, 29) that single strains are not able to mimic the behavior of all 930 
pathogenic strains tested. When utilized as a set, the non-pathogenic E. coli biotype I 931 
surrogates may provide a range of growth responses that may show them as appropriate 932 
surrogates for the non-O157 STECs.  933 
To replicate the use of the individual organisms as a set, the five surrogate 934 
organisms, the five rif-resistant surrogate organisms, and the six non-O157 STECs were 935 
combined and averaged to create means separation based on the three individual 936 
replications. The organisms were averaged to create one number to represent the five or 937 
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six individual organisms with the same characteristics. The individual organisms in the 938 
study were collectively run as sets to get a mean. The individual organisms were not 939 
combined and analyzed prior to data collection to truly represent a cocktail. The 940 
collection of the individual organisms was analyzed to remove strain-to-strain variation, 941 
and to look at how the organisms may grow as a set. There may be instances in where 942 
the use of the organisms as a cocktail would not be similar to collectively analyzing the 943 
individual means due to potential background effects on the organisms. Growth curves 944 
for sets of E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non- 945 
O157 STECs are shown in Figure 1. As shown in Table 2, there were no differences (P > 946 
0.05) between the initial population of the E. coli biotype I surrogates and the non-O157 947 
STECs. Throughout the evaluation, from 1-h to 10-h, the non-O157 STECs were not 948 
different (P > 0.05) from either the E. coli biotype I surrogates, both parent strains and 949 
rif-resistant strains, but not necessarily both at any given time point. The non-O157 950 
STECs were significantly different (P < 0.05) from the parent and rif-resistant E. coli 951 
biotype I surrogates by having a lower population at each given time point. A population 952 
of the non-O157 STECs that is lower than the E. coli biotype I surrogates is ideal for the 953 
organisms to properly represent the target pathogens for use as surrogates. By hour 12, 954 
all three groups of organisms, E. coli biotype I surrogates, E. coli biotype I rif-resistant 955 
surrogates, and the non-O157 STECs were not different (P > 0.05) through the 956 
completion of the 24-hour growth curve evaluation. While some statistical differences (P 957 
< 0.05) were detected at intervals during growth from an initial population of 958 
approximately log 3.0 to log 9.0 over twenty-four hours, trends were clearly within the 959 
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scope for use as surrogates. Within the scope for use of surrogates refers to the definition 960 
of a surrogate in having growth that is equivalent or greater than the growth of the target 961 
pathogens, which is supported by the data represented.  962 
Previously published research from Cabrera-Diaz et al. (8) evaluated growth 963 
parameters: growth rate, doubling time, maximum population density, and lag time. 964 
These data found few differences (P < 0.05) between the E. coli biotype I surrogates and 965 
the pathogenic E. coli O157:H7, which supports the data represented here that 966 
nonpathogenic surrogates might best represent pathogenic E. coli, specifically not O157, 967 
but the non-O157 STECs. In the Cabrera-Diaz et al. (8) study, the surrogates were 968 
determined to be appropriate for use to represent E. coli O157:H7, in that the 969 
populations were equivalent or greater in growth than the pathogen. In the data that is 970 
shown here, the surrogates were determined to be appropriate for use to represent the 971 
non-O157:H7 STECs, but there was not one surrogate that represented all of the non- 972 
O157 STECs appropriately, which is why the surrogates may be best utilized in a set 973 
versus individual organisms.  974 
 975 
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Table 1. Least squares means ± standard error of the mean for organisms comparing E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains in 
tryptic soy broth for growth at 37°C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Mean values were obtained from three independent replicates 
b SEM = Standard error of the least squares means 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 
d rif = rif-resistant organism 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM 
 
 
  Meana ± SEMb 
  Time (h) 
Organism  0 1 2 3 6 7 8 10 12 24 
BAA 1427  3.1 ± 0.0 BCDEFc 3.8 ± 0.1 A 4.5 ± 0.1 ABC 5.3 ± 0.1 BCD 8.0 ± 0.2 AB 8.2 ± 0.1 BCDE 8.7 ± 0.1 ABCD 8.8 ± 0.0 ABC 8.8 ± 0.2 A 8.8 ± 0.0 CDEF 
BAA 1428  3.3 ± 0.0 AB 3.7 ± 0.1 AB 4.5 ± 0.1 ABC 5.5 ± 0.1 AB 8.0 ± 0.2 A 8.3 ± 0.1 BCD 8.7 ± 0.1 ABCD 8.8 ± 0.0 ABCD 7.8 ± 0.2 B 8.9 ± 0.0 ABCDE 
BAA 1429  3.3 ± 0.0 A 3.7 ± 0.1 ABC 4.4 ± 0.1 ABC 5.4 ± 0.1 ABC 7.9 ± 0.2 ABC 8.3 ± 0.1 BCD 8.8 ± 0.1 ABC 8.8 ± 0.0 ABCD 8.8 ± 0.2 A 8.9 ± 0.0 ABCDE 
BAA 1430  3.3 ± 0.0 AB 3.8 ± 0.1 A 4.5 ± 0.1 ABC 5.4 ± 0.1 ABC 8.1 ± 0.2 A 8.6 ± 0.1 A 8.9 ± 0.1 A 8.8 ± 0.0 ABC 8.8 ± 0.2 A 8.9 ± 0.0 ABC 
BAA 1431  3.1 ± 0.0 CDEF 3.7 ± 0.1 AB 4.5 ± 0.1 ABC 5.5 ± 0.1 A 8.1 ± 0.2 A 8.5 ± 0.1 AB 8.9 ± 0.1 AB 8.8 ± 0.0 ABCD 8.7 ± 0.2 A 8.7 ± 0.0 FG 
BAA 1427 rifd  3.1 ± 0.0 DEF  3.7 ± 0.1 ABC 4.5 ± 0.1 AB 5.2 ± 0.1 DEF 7.4 ± 0.2 DE 7.9 ± 0.1 EF 8.5 ± 0.1 DE 8.8 ± 0.0 ABCD 8.7 ± 0.2 A 9.0 ± 0.0 AB 
BAA 1428 rif  3.2 ± 0.0 ABCD  3.6 ± 0.1 ABC 4.4 ± 0.1 BC 5.3 ± 0.1 CDE 7.5 ± 0.2 BCDE 8.0 ± 0.1 DEF 8.4 ± 0.1 EF 8.7 ± 0.0 D 8.7 ± 0.2 A 8.9 ± 0.0 ABCDE 
BAA 1429 rif  3.1 ± 0.0 EF  3.5 ± 0.1 ABC 4.4 ± 0.1 ABC 5.1 ± 0.1 FG 7.5 ± 0.2 BCDE 8.1 ± 0.1 CDE 8.7 ± 0.1 BCD 8.7 ± 0.0 BCD 8.7 ± 0.2 A 8.8 ± 0.0 CDEF 
BAA 1430 rif  3.1 ± 0.0 ABCDE 3.5 ± 0.1 ABC 4.3 ± 0.1 BC 5.2 ± 0.1 EF 7.4 ± 0.2 CDE 8.1 ± 0.1 DE 8.6 ± 0.1 CD 8.7 ± 0.0 ABCD 8.8 ± 0.2 A 9.0 ± 0.0 A 
BAA 1431 rif  3.0 ± 0.0 F 3.5 ± 0.1 ABC 4.6 ± 0.1 A 5.4 ± 0.1 ABC 7.8 ± 0.2 ABCDE 8.4 ± 0.1 ABC 8.8 ± 0.1 ABC 8.7 ± 0.0 CD 8.7 ± 0.2 A 8.7 ± 0.0 G 
BAA-2219e  3.2 ± 0.0 ABC 3.6 ± 0.1 ABC 4.5 ± 0.1 ABC 5.4 ± 0.1 ABC 7.7 ± 0.2 ABCDE 8.4 ± 0.1 ABC 8.8 ± 0.1 ABC 8.8 ± 0.0 ABCD 8.8 ± 0.2 A 8.8 ± 0.0 EFG 
BAA-2217  3.2 ± 0.0 ABCDE 3.5 ± 0.1 ABC 4.4 ± 0.1 ABC 5.4 ± 0.1 ABC 8.0 ± 0.2 AB 8.5 ± 0.1 AB 8.9 ± 0.1 AB 8.8 ± 0.0 ABCD 8.8 ± 0.2 A 8.9 ± 0.0 BCDE 
BAA-2215  3.3 ± 0.0 AB 3.4 ± 0.1 C 4.3 ± 0.1 BC 5.1 ± 0.1 FG 7.3 ± 0.2 E 8.0 ± 0.1 DEF 8.6 ± 0.1 CD 8.8 ± 0.0 AB 8.7 ± 0.2 A 8.8 ± 0.0 DEFG 
BAA-2196  3.2 ± 0.0 ABCDE 3.4 ± 0.1 BC 4.1 ± 0.1 D 4.9 ± 0.1 G 7.5 ± 0.2 BCDE 7.7 ± 0.1 F 8.3 ± 0.1 F 8.7 ± 0.0 ABCD 8.8 ± 0.2 A 8.9 ± 0.0 ABC 
BAA-2193  3.2 ± 0.0 ABCDE 3.5 ± 0.1 ABC 4.3 ± 0.1 CD 5.2 ± 0.1 EF 7.7 ± 0.2 ABCDE 8.4 ± 0.1 ABC 8.8 ± 0.1 ABC 8.8 ± 0.0 A 8.8 ± 0.2 A 8.9 ± 0.0 ABCD 
BAA-2192  3.2 ± 0.0 ABCDE 3.6 ± 0.1 ABC 4.5 ± 0.1 ABC 5.3 ± 0.1 BCD 7.8 ± 0.2 ABCD 8.5 ± 0.1 AB 8.8 ± 0.1 ABC 8.7 ± 0.0 ABCD 8.8 ± 0.2 A 8.8 ± 0.0 CDEF 
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Table 2. Least squares means ± standard error of the mean for organisms comparing E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains in sets 
for growth in tryptic soy broth at 37°C 
a Mean values were obtained from three independent replicates 
b SEM = Standard error of the least squares means 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 
d E. coli surrogates include BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 strains 
e Rif-resistant E. coli surrogates include rif-resistant strains BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 
f BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM 
 
  Meana ± SEMb 
  Time (h) 
Organism  0 1 2 3 6 7 8 10 12 24 
E. coli surrogatesd  3.2 ± 0.0 Ac 3.7 ± 0.0 A 4.5 ± 0.0 A 5.4 ± 0.0 A 8.0 ± 0.1 A 8.4 ± 0.1 A 8.8 ± 0.1 A 8.8 ± 0.0 A 8.6 ± 0.1 A 8.9 ± 0.0 A 
Rif-resistante E. coli surrogates  3.1 ± 0.0 B 3.6 ± 0.0 B 4.5 ± 0.0 AB 5.2 ± 0.0 B 7.5 ± 0.1 B 8.1 ± 0.1 B 8.6 ± 0.1 B 8.7 ± 0.0 B 8.7 ± 0.1 A 8.9 ± 0.0 A 
Non-O157:H7 STECsf  3.2 ± 0.0 A 3.5 ± 0.0 B 4.4 ± 0.0 B 5.2 ± 0.0 B 7.7 ± 0.1 B 8.2 ± 0.1 AB 8.7 ± 0.0 AB 8.8 ± 0.0 A 8.8 ± 0.1 A 8.8 ± 0.0 A 
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Figure 1. Growth curves for sets of E. coli biotype I surrogates, rif-resistant E. coli 
biotype I surrogates, and non-O157 STECs strains in tryptic soy broth at 37°C 
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Acid resistance 7 
The acid resistance of E. coli biotype I surrogate microorganisms, and the non- 8 
O157 STECs were compared in PBS acidified with L-lactic acid at pH values 2.5, 3.0, 9 
and 3.5. This pH range was selected based on the expected carcass surface pH after 10 
application of 2% L-lactic acid (22). To be used in the validation of lactic acid 11 
interventions, surrogate organisms would ideally have resistance to lactic acid similar to 12 
that of the target pathogens (six non-O157 STECs). All cultures were grown to 13 
stationary phase in TSB and in TSB+G to induce their acid tolerance. It has been 14 
demonstrated that E. coli cultures grown in the presence of glucose reduces the pH in the 15 
medium, and induces a pH-dependent acid tolerance response (5). It has been reported 16 
that culturing enterohemorrhagic E. coli in the presence of glucose reduced the pH in the 17 
medium during the growth of the microorganisms making the cells more resistant to 18 
subsequent exposure to acidic conditions (5, 6). In the intestinal tract of cattle, enteric 19 
pathogens, such as E. coli O157:H7 and Salmonella are exposed to a reduced pH 20 
condition due to the presence of volatile fatty acids. The exposure to mild acidic 21 
conditions has been demonstrated to increase their acid resistance.  22 
Log reductions (CFU/ml) after initial, 0.5, 1.0 1.5, and 2.0 h of exposure to acidic 23 
conditions at pH 2.5, 3.0, and 3.5 were calculated and compared among the sixteen 24 
organisms included in this study, the five E. coli biotype I surrogates, the five E. coli rif- 25 
resistant biotype I surrogates, and the six non-O157 STECs. For acid resistance, most E. 26 
coli biotype I microorganisms had similar (P > 0.05) reductions to the non-O157 STECs; 27 
however, there were some instances of greater reductions (P < 0.05). For example, the 28 
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stationary phase organisms at pH 3.0, at the initial time point, organism BAA-1428 29 
showed the greatest reduction at 3.1 log CFU/ml compared to the other fifteen organisms 30 
showing reductions from 2.2-2.9. For the stationary phase organisms at pH 3.5, the 0.5- 31 
h, organism BAA-1430 showed the greatest reduction (3.2 vs. 0.9-2.6) log CFU/ml, and 32 
at the 1-h time point, BAA-1430 reduced 3.9 CFU/ml compared to 1.3-3.8. Acid-adapted 33 
organisms at pH 2.5, organism BAA-1429 showed the greatest initial reduction at 4.3 34 
compared to 3.6-4.2 log CFU/ml. Acid-adapted organisms at pH 3.0, following the 2-h 35 
exposure time, organism BAA-1430 showed the greatest reduction at 7.4 compared to 36 
5.1-7.0 log CFU/ml. Acid-adapted organisms at pH 3.5, following the 0.5-h time point, 37 
organism 1428 showed the greatest reduction at 2.6 log CFU/ml compared to 1.9-2.4, 38 
and at 1-h, organisms BAA-1427 showed the greatest reduction at 2.6 compared to 2.1- 39 
2.5 log CFU/ml. These data support previously published data stating that the surrogate 40 
organisms (log reductions CFU/ml) were not different (P > 0.05) from E. coli O157:H7 41 
(8).  42 
Stationary phase organisms at pH 2.5 were not compared using a least squares 43 
means separation due to missing data points at the initial level, which did not allow for 44 
subsequent analysis. The initial reduction ranged from 3.9-4.5 log CFU/ml, and the final 45 
log reduction following exposure to L-lactic acid acidified to pH 2.5 ranged from 6.7-7.6 46 
log CFU/ml. Table 3 shows the stationary phase organisms at pH 3.0. Initially, there 47 
were differences (P < 0.05) between the sixteen individual organisms; however, 48 
following the 2.0-h exposure time, the differences (P < 0.05) were less variable, and the 49 
six non-O157 STECs were comparable with at least one E. coli biotype I surrogate or 50 
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one E. coli rif-resistant biotype I surrogate, if not more. Table 4 shows the stationary 51 
phase organisms at pH 3.5. Initially the log reductions (CFU/ml) ranged from 0.4-2.2. 52 
All organisms were not different (P > 0.05) except for organism BAA-1430 rif at the 53 
initial log reduction (CFU/ml) time point. At the one hour time point, BAA-1430 rif was 54 
different (P < 0.05) from the other fifteen organisms at a lower reduction of only 1.3 log 55 
CFU/ml compared to 2.5-3.8 log CFU/ml reduction. After 2 h exposure to L-lactic acid 56 
at pH 3.5 the log reductions (CFU/ml) varied from 2.3-5.1 with organism BAA-2192 57 
showing the greatest reduction at 5.1 log CFU/ml.  58 
The acid-adapted organisms (TSB+G) acidified with L-lactic acid at pH 2.5 are 59 
shown in Table 5. Initially, log reductions (CFU/ml) ranged from 3.6-4.3, and after 2 h 60 
exposure time to L-lactic acid at pH 2.5, the log reductions (CFU/ml) ranged from 5.7- 61 
7.5. At the 1-h time interval, BAA-1427 rif was the only organism that was different (P 62 
< 0.05) from the other fifteen organisms at 5.4 log reduction CFU/ml compared to 6.6- 63 
7.5 log reduction CFU/ml. Organism BAA-1427 rif, at the 1-h time interval showed 64 
more resistance to the pH, and did not have as great of a reduction as the other fifteen 65 
organisms. More research may be needed to understand the possible mechanism between 66 
the rif-resistant, and potential adaptations to pH. Further data collection may show that a 67 
resistance to an antibiotic may allow for the organism to have a greater resistance to pH 68 
or temperature. Table 6 shows all sixteen organisms, acid-adapted, and exposed to L- 69 
lactic acid at pH 3.0. Initially, the log reductions (CFU/ml) ranged from 1.7-2.5; 70 
however, organism BAA-2196 was different (P < 0.05) from the other fifteen organisms, 71 
showing the greatest initial log reduction (CFU/ml) at 2.5. Following exposure for 2 h 72 
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reductions ranged from 5.1-7.4 log CFU/ml at pH 3.0. Data shown in Table 7 represent 73 
all sixteen organisms, acid-adapted, and exposed to L-lactic acid at pH 3.5. Initially, log 74 
reductions (CFU/ml) ranged from 1.8-2.1, and final log reductions (CFU/ml) ranged 75 
from 2.7-3.7. Organism BAA-1431 showed a total reduction after 2-h exposure at pH 3.0 76 
(stationary phase) of 4.1 log CFU/ml, 1.2 log at pH 3.5 (stationary phase), 2.9 log at pH 77 
2.5 (acid-adapted), 5.2 log at pH 3.0 (acid-adapted), and 1.6 log at pH 3.5 (acid- 78 
adapted). Organism BAA-1431 showed greater reductions at a higher pH compared to 79 
the lower pH value. Organisms respond differently to stress. It is interesting to note that 80 
strain-to-strain variation does occur. Since each processing condition is unique, how the 81 
organisms are expected to react may not actually be the way they react to each individual 82 
experiment.  83 
 84 
. 85 
 86 
 87 
 88 
 89 
 90 
 91 
 92 
 93 
 94 
 95 
 96 
 97 
 98 
 99 
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 100 
Table 3. Mean reductions (log CFU/ml) for stationary phase E. coli biotype I surrogates, rif-resistant E. 101 
coli biotype I surrogates, and non-O157 STECs strains after exposure to phosphate buffered saline 102 
acidified with L-lactic acid at pH 3.0 at 37°C 103 
 104 
 105 
 106 
 107 
 108 
 109 
 110 
 111 
 112 
 113 
 114 
 115 
 116 
 117 
 118 
 119 
 120 
 121 
 122 
 123 
 124 
 125 
 126 
 127 
 128 
 129 
 130 
 131 
 132 
a Mean values were obtained from three independent replicates 133 
b SEM = Standard error of the least squares means 134 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 135 
d rif = rif-resistant organism 136 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 137 
O45:H2, BAA-2192 = O145:NM   138 
  Mean reductiona ± SEMb 
  Exposure time (h) 
Organism  0 0.5 1 1.5 2 
BAA 1427  2.3 ± 0.2 Ec 5.1 ± 0.4 BCDE 5.8 ± 0.6 ABC 5.6 ± 0.6 B 6.3 ± 0.5 AB 
BAA 1428  3.1 ± 0.2 A 5.5 ± 0.4 ABCD 6.4 ± 0.6 ABC 6.5 ± 0.6 AB 7.3 ± 0.5 AB 
BAA 1429  2.3 ± 0.2 DE 5.9 ± 0.4 ABC 6.4 ± 0.6 ABC 6.3 ± 0.6 AB 6.8 ± 0.5 AB 
BAA 1430  2.9 ± 0.2 AB 5.3 ± 0.4 BCD 6.0 ± 0.6 ABC 6.4 ± 0.6 AB 7.2 ± 0.5 AB 
BAA 1431  2.3 ± 0.2 CDE 4.9 ± 0.4 CDE 5.3 ± 0.6 BC 6.5 ± 0.6 AB 6.4 ± 0.5 AB 
BAA 1427 rifd  2.3 ± 0.2 E 4.4 ± 0.4 DE 5.1 ± 0.6 BC 5.9 ± 0.6 AB 7.0 ± 0.5 AB 
BAA 1428 rif  2.2 ± 0.2 E 4.5 ± 0.4 DE 5.9 ± 0.6 ABC 5.5 ± 0.6 B 6.6 ± 0.5 AB 
BAA 1429 rif  2.3 ± 0.2 CDE 4.0 ± 0.4 E 6.1 ± 0.6 ABC 5.3 ± 0.6 B 6.6 ± 0.5 AB 
BAA 1430 rif  2.2 ± 0.2 E 4.3 ± 0.4 DE 5.3 ± 0.6 BC 5.5 ± 0.6 B 7.2 ± 0.5 AB 
BAA 1431 rif  2.4 ± 0.2 BCDE 4.3 ± 0.4 DE 4.7 ± 0.6 C 5.3 ± 0.6 B 7.2 ± 0.5 AB 
BAA-2219e  2.8 ± 0.2 ABCDE 6.0 ± 0.4 ABC 6.7 ± 0.6 AB 6.5 ± 0.6 AB 7.6 ± 0.5 A 
BAA-2217  2.8 ± 0.2 AB 4.9 ± 0.4 BCDE 6.3 ± 0.6 ABC 7.5 ± 0.6 A 7.6 ± 0.5 A 
BAA-2215  2.5 ± 0.2 BCDE 5.9 ± 0.4 ABC 5.5 ± 0.6 ABC 6.6 ± 0.6 AB 6.8 ± 0.5 AB 
BAA-2196  2.7 ± 0.2 ABCDE 6.2 ± 0.4 AB 6.2 ± 0.6 ABC 6.6 ± 0.6 AB 6.0 ± 0.5 B 
BAA-2193  2.7 ± 0.2 ABCDE 5.4 ± 0.4 ABCD 7.2 ± 0.6 A 6.1 ± 0.6 AB 7.2 ± 0.5 AB 
BAA-2192  2.8 ± 0.2 ABC 6.6 ± 0.4 A 6.5 ± 0.6 ABC 5.8 ± 0.6 AB 6.0 ± 0.5 B 
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Table 4. Mean reductions (log CFU/ml) for stationary phase E. coli biotype I surrogates, rif-resistant E. coli 139 
biotype I surrogates, and non-O157 STECs strains after exposure to phosphate buffered saline acidified with 140 
L-lactic acid at pH 3.5 at 37°C 141 
 142 
 143 
 144 
 145 
 146 
 147 
 148 
 149 
 150 
 151 
 152 
 153 
 154 
 155 
 156 
 157 
 158 
a Mean values were obtained from three independent replicates 159 
b SEM = Standard error of the least squares means 160 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 161 
d rif = rif-resistant organism 162 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 163 
O45:H2, BAA-2192 = O145:NM   164 
  Mean reductiona ± SEMb 
  Exposure time (h) 
Organism  0 0.5 1 1.5 2 
BAA 1427  1.8 ± 0.3 Ac 2.5 ± 0.4 A 2.8 ± 0.4 ABC 2.8 ± 0.5 CD 3.3 ± 0.4 DEF 
BAA 1428  2.1 ± 0.3 A 2.2 ± 0.4 AB 3.0 ± 0.4 ABC 2.8 ± 0.5 CD 3.3 ± 0.4 DEF 
BAA 1429  1.7 ± 0.3 A 2.1 ± 0.4 AB 2.6 ± 0.4 C 2.7 ± 0.5 CD 3.4 ± 0.4 DEF 
BAA 1430  1.7 ± 0.3 A 3.2 ± 0.4 A 3.9 ± 0.4 A 3.9 ± 0.5 ABC 3.9 ± 0.4 BCDE 
BAA 1431  1.8 ± 0.3 A 2.3 ± 0.4 A 2.5 ± 0.4 C 2.6 ± 0.5 CD 3.0 ± 0.4 EF 
BAA 1427 rifd  1.7 ± 0.3 A 2.3 ± 0.4 A 2.6 ± 0.4 BC 2.6 ± 0.5 CD 3.2 ± 0.4 DEF 
BAA 1428 rif  2.2 ± 0.3 A 2.3 ± 0.4 A 3.4 ± 0.4 ABC 2.9 ± 0.5 CD 3.3 ± 0.4 DEF 
BAA 1429 rif  2.2 ± 0.3 A 2.3 ± 0.4 A 2.9 ± 0.4 ABC 2.9 ± 0.5 CD 3.2 ± 0.4 DEF 
BAA 1430 rif  0.4 ± 0.3 B 0.9 ± 0.4 B 1.3 ± 0.4 D 1.5 ± 0.5 D 2.3 ± 0.4 F 
BAA 1431 rif  1.8 ± 0.3 A 2.3 ± 0.4 A 2.9 ± 0.4 ABC 2.6 ± 0.5 CD 3.6 ± 0.4 CDE 
BAA-2219e  1.9 ± 0.3 A 2.3 ± 0.4 A 3.0 ± 0.4 ABC 3.2 ± 0.5 BC 3.6 ± 0.4 CDE 
BAA-2217  1.8 ± 0.3 A 2.6 ± 0.4 A 3.7 ± 0.4 ABC 4.7 ± 0.5 A 5.3 ± 0.4 A 
BAA-2215  1.7 ± 0.3 A 2.3 ± 0.4 A 3.0 ± 0.4 ABC 3.6 ± 0.5 ABC 4.3 ± 0.4 ABCD 
BAA-2196  1.7 ± 0.3 A 2.1 ± 0.4 AB 2.7 ± 0.4 ABC 3.0 ± 0.5 BC 3.7 ± 0.4 CDE 
BAA-2193  1.7 ± 0.3 A 2.6 ± 0.4 A 3.8 ± 0.4 ABC 4.0 ± 0.5 ABC 4.7 ± 0.4 ABC 
BAA-2192  1.7 ± 0.3 A 2.6 ± 0.4 A 3.2 ± 0.4 ABC 4.4 ± 0.5 AB 5.1 ± 0.4 AB 
  44 
Table 5. Mean reductions (log CFU/ml) for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli biotype 165 
I surrogates, and non-O157 STECs strains after exposure to phosphate buffered saline acidified with L-lactic 166 
acid at pH 2.5 at 37°C 167 
a Mean values were obtained from three independent replicates 168 
b SEM = Standard error of the least squares means 169 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 170 
d rif = rif-resistant organism 171 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 172 
O45:H2, BAA-2192 = O145:NM   173 
  Mean reductiona ± SEMb 
  Exposure time (h) 
Organism  0 0.5 1 1.5 2 
BAA 1427  3.6 ± 0.2 Cc 7.2 ± 0.6 AB 7.3 ± 0.4 A 7.3 ± 0.3 ABC 7.3 ± 0.4 A 
BAA 1428  4.1 ± 0.2 ABC 6.9 ± 0.6 AB 7.2 ± 0.4 A 6.9 ± 0.3 ABCD 6.9 ± 0.4 A 
BAA 1429  4.3 ± 0.2 A 6.5 ± 0.6 AB 6.6 ± 0.4 A 6.7 ± 0.3 ABCD 6.8 ± 0.4 AB 
BAA 1430  3.7 ± 0.2 C 6.8 ± 0.6 AB 6.7 ± 0.4 A 6.5 ± 0.3 BCD 6.6 ± 0.4 AB 
BAA 1431  4.1 ± 0.2 ABC 6.8 ± 0.6 AB 6.8 ± 0.4 A 7.4 ± 0.3 A 7.0 ± 0.4 A 
BAA 1427 rifd  3.8 ± 0.2 ABC 5.8 ± 0.6 B 5.4 ± 0.4 B 7.2 ± 0.3 ABCD 6.8 ± 0.4 AB 
BAA 1428 rif  3.6 ± 0.2 C 7.4 ± 0.6 AB 7.1 ± 0.4 A 7.3 ± 0.3 ABCD 7.2 ± 0.4 A 
BAA 1429 rif  3.7 ± 0.2 C 6.7 ± 0.6 AB 7.4 ± 0.4 A 7.3 ± 0.3 ABC 7.4 ± 0.4 A 
BAA 1430 rif  4.0 ± 0.2 ABC 6.4 ± 0.6 AB 7.4 ± 0.4 A 6.5 ± 0.3 BCD 7.4 ± 0.4 A 
BAA 1431 rif  3.6 ± 0.2 C 6.7 ± 0.6 AB 6.6 ± 0.4 A 6.5 ± 0.3 CD 7.3 ± 0.4 A 
BAA-2219e  4.0 ± 0.2 ABC 6.5 ± 0.6 AB 6.7 ± 0.4 A 7.4 ± 0.3 A 6.5 ± 0.4 AB 
BAA-2217  3.7 ± 0.2 BC 7.4 ± 0.6 A 7.5 ± 0.4 A 7.4 ± 0.3 AB 7.5 ± 0.4 A 
BAA-2215  3.8 ± 0.2 BC 6.5 ± 0.6 AB 7.4 ± 0.4 A 6.4 ± 0.3 D 7.0 ± 0.4 A 
BAA-2196  4.0 ± 0.2 ABC 6.1 ± 0.6 AB 6.9 ± 0.4 A 7.1 ± 0.3 ABCD 7.3 ± 0.4 A 
BAA-2193  3.8 ± 0.2 BC 6.9 ± 0.6 AB 7.4 ± 0.4 A 7.4 ± 0.3 AB 5.7 ± 0.4 B 
BAA-2192  4.2 ± 0.2 AB 7.0 ± 0.6 AB 7.3 ± 0.4 A 7.4 ± 0.3 A 7.4 ± 0.4 A 
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Table 6. Mean reductions (log CFU/ml) for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli 174 
biotype I surrogates, and non-O157 STECs strains after exposure to phosphate buffered saline acidified with 175 
L-lactic acid at pH 3.0 at 37°C 176 
 177 
 178 
 179 
 180 
 181 
 182 
 183 
 184 
 185 
 186 
 187 
 188 
 189 
 190 
 191 
 192 
 193 
 194 
 195 
 196 
 197 
 198 
 199 
 200 
 201 
 202 
 203 
 204 
 205 
 206 
 207 
 208 
 209 
 210 
 211 
 212 
 213 
 214 
 215 
 216 
 217 
 218 
 219 
 220 
 221 
a Mean values were obtained from three independent replicates 222 
b SEM = Standard error of the least squares means 223 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 224 
d rif = rif-resistant organism 225 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 226 
O45:H2, BAA-2192 = O145:NM   227 
  Mean reductiona ± SEMb 
  Exposure time (h) 
Organism  0 0.5 1 1.5 2 
BAA 1427  1.8 ± 0.1 CDEc 4.0 ± 0.2 DEF 4.6 ± 0.3 DEF 5.4 ± 0.3 CD 5.1 ± 0.4 C 
BAA 1428  2.1 ± 0.1 B 4.4 ± 0.2 BCD 5.3 ± 0.3 BCD 6.4 ± 0.3 AB 6.4 ± 0.4 ABC 
BAA 1429  2.0 ± 0.1 BCDE 4.7 ± 0.2 BC 5.3 ± 0.3 BCD 6.7 ± 0.3 AB 7.0 ± 0.4 AB 
BAA 1430  1.9 ± 0.1 BCDE 4.6 ± 0.2 BC 5.6 ± 0.3 ABC 6.6 ± 0.3 AB 7.4 ± 0.4 A 
BAA 1431  1.8 ± 0.1 DE 3.7 ± 0.2 FGH 4.2 ± 0.3 F 5.3 ± 0.3 CD 7.0 ± 0.4 AB 
BAA 1427 rifd  1.9 ± 0.1 BCDE 3.3 ± 0.2 H 4.2 ± 0.3 F 4.7 ± 0.3 D 6.1 ± 0.4 BC 
BAA 1428 rif  2.0 ± 0.1 BCD 3.9 ± 0.2 EFG 4.6 ± 0.3 DEF 5.4 ± 0.3 CD 5.8 ± 0.4 BC 
BAA 1429 rif  2.0 ± 0.1 BCDE 3.5 ± 0.2 FGH 4.4 ± 0.3 EF 5.2 ± 0.3 D 5.4 ± 0.4 C 
BAA 1430 rif  1.7 ± 0.1 E 3.5 ± 0.2 GH 4.3 ± 0.3 F 5.1 ± 0.3 D 5.4 ± 0.4 C 
BAA 1431 rif  2.0 ± 0.1 BCDE 3.8 ± 0.2 FGH 4.2 ± 0.3 F 4.8 ± 0.3 D 5.4 ± 0.4 C 
BAA-2219e  1.9 ± 0.1 BCDE 4.3 ± 0.2 CDE 4.7 ± 0.3 DEF 5.1 ± 0.3 D 5.2 ± 0.4 C 
BAA-2217  1.9 ± 0.1 BCDE 4.9 ± 0.2 AB 6.0 ± 0.3 AB 6.1 ± 0.3 BC 6.1 ± 0.4 BC 
BAA-2215  2.1 ± 0.1 BC 4.5 ± 0.2 BCD 5.3± 0.3 BCD 6.4 ± 0.3 AB 5.9 ± 0.4 BC 
BAA-2196  2.5 ± 0.1 A 5.3 ± 0.2 A 6.1 ± 0.3 AB 6.9 ± 0.3 A 6.9 ± 0.4 AB 
BAA-2193  1.9 ± 0.1 BCDE 4.5 ± 0.2 BC 5.2 ± 0.3 CDE 6.6 ± 0.3 AB 7.0 ± 0.4 AB 
BAA-2192  1.9 ± 0.1 BCDE 4.5 ± 0.2 BC 6.4 ± 0.3 A 6.8 ± 0.3 AB 6.0 ± 0.4 BC 
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Table 7. Mean reductions (log CFU/ml) for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli 228 
biotype I surrogates, and non-O157 STECs strains after exposure to phosphate buffered saline acidified with 229 
L-lactic acid at pH 3.5 at 37°C 230 
 231 
 232 
 233 
 234 
 235 
 236 
 237 
 238 
 239 
 240 
 241 
 242 
 243 
 244 
 245 
 246 
 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
 271 
 272 
 273 
 274 
 275 
a Mean values were obtained from three independent replicates 276 
b SEM = Standard error of the least squares means 277 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 278 
d rif = rif-resistant organism 279 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 280 
O45:H2, BAA-2192 = O145:NM   281 
  Mean reductiona ± SEMb 
  Exposure time (h) 
Organism  0 0.5 1 1.5 2 
BAA 1427  1.9 ± 0.1 ABCc 1.9 ± 0.2 C 2.6 ± 0.2 A 2.6 ± 0.2 ABC 3.5 ± 0.3 AB 
BAA 1428  2.1 ± 0.1 A 2.6 ± 0.2 A 2.2 ± 0.2 AB 2.5 ± 0.2 BC 2.9 ± 0.3 AB 
BAA 1429  1.8 ± 0.1 BC 1.9 ± 0.2 C 2.1 ± 0.2 B 2.2 ± 0.2 C 3.5 ± 0.3 AB 
BAA 1430  1.9 ± 0.1 ABC 2.4 ± 0.2 AB 2.3 ± 0.2 AB 2.8 ± 0.2 ABC 3.3 ± 0.3 AB 
BAA 1431  2.0 ± 0.1 ABC 2.0 ± 0.2 BC 2.2 ± 0.2 AB 2.4 ± 0.2 BC 3.6 ± 0.3 A 
BAA 1427 rifd  1.9 ± 0.1 ABC 2.1 ± 0.2 BC 2.2 ± 0.2 AB 2.5 ± 0.2 BC 3.1 ± 0.3 AB 
BAA 1428 rif  2.1 ± 0.1 A 1.9 ± 0.2 BC 2.2 ± 0.2 AB 2.7 ± 0.2 ABC 2.7 ± 0.3 B 
BAA 1429 rif  2.1 ± 0.1 ABC 2.3 ± 0.2 ABC 2.3 ± 0.2 AB 2.5 ± 0.2 ABC 3.0 ± 0.3 AB 
BAA 1430 rif  1.9 ± 0.1 ABC 2.0 ± 0.2 BC 2.3 ± 0.2 AB 2.5 ± 0.2 BC 3.0 ± 0.3 AB 
BAA 1431 rif  2.0 ± 0.1 ABC 2.0 ± 0.2 BC 2.3 ± 0.2 AB 2.5 ± 0.2 BC 2.9 ± 0.3 AB 
BAA-2219e  2.1 ± 0.1 A 2.1 ± 0.2 BC 2.4 ± 0.2 AB 2.5 ± 0.2 BC 3.4 ± 0.3 AB 
BAA-2217  1.8 ± 0.1 C 2.0 ± 0.2 BC 2.4 ± 0.2 AB 3.1 ± 0.2 A 3.6 ± 0.3 A 
BAA-2215  2.1 ± 0.1 A 2.2 ± 0.2 ABC 2.5 ± 0.2 AB 2.7 ± 0.2 ABC 3.6 ± 0.3 A 
BAA-2196  2.1 ± 0.1 AB 2.3 ± 0.2 ABC 2.5 ± 0.2 AB 2.7 ± 0.2 ABC 3.3 ± 0.3 AB 
BAA-2193  2.0 ± 0.1 ABC 2.1 ± 0.2 BC 2.4 ± 0.2 AB 2.9 ± 0.2 AB 3.3 ± 0.3 AB 
BAA-2192  1.9 ± 0.1 ABC 2.0 ± 0.2 BC 2.3 ± 0.2 AB 2.9 ± 0.2 AB 3.7 ± 0.3 A 
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Table 8 shows the sets of organisms that were analyzed together to create a mean 282 
for the E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and the non- 283 
O157 STECs. These data were combined to eliminate individual strain-to-strain 284 
variation to determine the potential use of the surrogates as a cocktail to represent all of 285 
the non-O157 STECs. For the stationary phase organisms at pH 2.5, these data were 286 
omitted due to the majority of the log reduction counts (CFU/ml) falling below the level 287 
of detection. The stationary phase organisms at pH 3.0 (Figure 2) showed no differences 288 
(P > 0.05) between the biotype I surrogate organisms and the non-O157 STECs 289 
throughout the 2-hour evaluation. At hour 0, 0.5, and 1.5, the rif-resistant biotype I 290 
surrogate organisms were different (P < 0.05) from the biotype I surrogates and the non- 291 
O157 STECs by showing lower log reductions (CFU/ml). At hour 1.0, the biotype I 292 
surrogates, and the rif-resistant biotype I surrogates were not different (P > 0.05), and at 293 
the 2-h time point, there were no differences (P > 0.05) between the three groups of 294 
organisms evaluated. Though there were differences at the varying time points, by the 295 
end of the 2-h evaluation, all three groups of organisms were not different (P > 0.05), 296 
which may be useful in identifying the biotype I surrogates appropriate to represent the 297 
behavior of the non-O157 STECs. For the stationary phase organisms at pH 3.5 (Figure 298 
3), at time point zero and 0.5-h, there were no differences (P > 0.05) between the biotype 299 
I surrogates, rif-resistant biotype I surrogates, and the non-O157 STECs. At 1-h, there 300 
were no differences (P > 0.05) between the biotype I surrogates and the non-O157 301 
STECs, and the rif-resistant biotype I surrogates were not different (P > 0.05) from the 302 
biotype I surrogates. At hour 1.5 and two, there were no differences (P > 0.05) between 303 
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the biotype I surrogates and the rif-resistant biotype I surrogates; however, the non-O157 304 
STECs were different (P < 0.05), representing a greater log reduction count (CFU/ml). 305 
After exposure of the organisms to L-lactic acid acidified to pH 3.5, biotype I surrogates 306 
may be reduced, but the non-O157 STECs may be reduced to a greater log reduction 307 
count (CFU/ml).  308 
Acid-adapted organisms at pH 2.5 (Figure 4) showed no differences (P > 0.05) 309 
between the biotype I surrogates, the rif-resistant surrogates, and the non-O157 STECs 310 
throughout the entire 2-h evaluation. Initial log reduction counts were 3.7-4.0 CFU/ml, 311 
and after 2-h, log reduction counts ranged from 6.9-7.2 CFU/ml. Acid-adapted 312 
organisms at pH 3.0 (Figure 5) showed no differences (P > 0.05) between the biotype I 313 
surrogates, rif-resistant biotype I surrogates, and the non-O157 STECs at the initial time 314 
point (1.9-2.0 log reductions (CFU/ml)). At the 0.5-h, and 1-h time point, all three 315 
groups of organisms were different (P < 0.05); however, the non-O157 STECs showed a 316 
greater log reduction count (CFU/ml). The non-O157 STECs showed a greater log 317 
reduction, which may mean the organisms, have a lower resistance to pH 3.0. For use as 318 
a surrogate, the E. coli biotype I surrogates would ideally have a higher resistance to the 319 
pH, showing a lower reduction when compared to the non-O157 STECs. These data may 320 
support the use of the surrogates to represent the non-O157 STECs, as the surrogates 321 
show a lower reduction, indicating a higher resistance to the pH value. At the 1.5-h time 322 
point evaluation, the biotype I surrogates and the non-O157 STECs were not different (P 323 
> 0.05) but the rif-resistant biotype I surrogates were different (P < 0.05). At the final 2- 324 
h time point evaluation, the non-O157 STECs were not different (P > 0.05) from the 325 
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biotype I surrogates or the rif-resistant surrogates, but there was a difference (P < 0.05) 326 
between the biotype I surrogates and the rif-resistant surrogates. Acid-adapted organisms 327 
at pH 3.5 (Figure 6) showed no differences (P > 0.05) between the biotype I surrogates, 328 
rif-resistant biotype I surrogates, and non-O157 STECs at the initial, 0.5-h and 1-h time 329 
point. At the 1.5-hour time point, there were no differences (P > 0.05) between the 330 
biotype I surrogates and the rif-resistant biotype I surrogates, but there was a difference 331 
(P < 0.05) between the biotype I surrogates, rif-resistant surrogates, and the non-O157 332 
STECs. The non-O157 STECs did have a greater log reduction count (CFU/ml) (2.5 vs. 333 
2.8, respectively). At the 2-h time point, there was no difference (P > 0.05) between the 334 
biotype I surrogates and the non-O157 STECs; however, the rif-resistant surrogates were 335 
different (P < 0.05) (3.4, 3.5 and 2.9 log reduction CFU/ml, respectively). 336 
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Table 8. Mean reductions (log CFU/ml) for E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains in sets after exposure to 
phosphate buffered saline acidified with L-lactic acid at 37°C 
a Mean values were obtained from three independent replicates 
b SEM = Standard error of the least squares means 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 
d E. coli surrogates include BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 strains 
e Rif-resistant E. coli surrogates include rif-resistant strains BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 
f BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM 
  Mean reductiona ± SEMb 
  Exposure time (h) 
Organism   0  0 .5 1 0.5  1.0 1.5 2.0 
  Stationary/pH 3.0 
E. coli surrogatesd  2.6 ± 0.1 Ac 5.3 ± 0.2 A 6.0 ± 0.3 AB 6.3 ± 0.3 A 6.8 ± 0.2 A 
rif-resistante E. coli surrogates  2.3 ± 0.1 B 4.3 ± 0.2 B 5.4 ± 0.3 B 5.5 ± 0.3 B 6.9 ± 0.2 A 
Non-O157:H7 STECsf  2.7 ± 0.1 A 5.8 ± 0.2 A 6.4 ± 0.2 A 6.5 ± 0.2 A 6.9 ± 0.2 A 
  Stationary/pH 3.5 
E. coli surrogates  1.8 ± 0.2 A 2.5 ± 0.2 A 2.9 ± 0.2 AB 3.0 ± 0.2 B 3.4 ± 0.2 B 
rif-resistant E. coli surrogates  1.7 ± 0.2 A 2.0 ± 0.2 A 2.6 ± 0.2 B 2.5 ± 0.2 B 3.1 ± 0.2 B 
Non-O157:H7 STECs  1.7 ± 0.2 A 2.4 ± 0.2 A 3.2 ± 0.2 A 3.8 ± 0.2 A 4.5 ± 0.2 A 
  Acid-adapted/pH 2.5 
E. coli surrogates  4.0 ± 0.1 A 6.8 ± 0.2 A 6.9 ± 0.2 A 7.0 ± 0.2 A 6.9 ± 0.2 A 
rif-resistant E. coli surrogates  3.7 ± 0.1 A 6.6 ± 0.2 A 6.8 ± 0.2 A 7.0 ± 0.2 A 7.2 ± 0.2 A 
Non-O157:H7 STECs  3.9 ± 0.1 A 6.7 ± 0.2 A 7.2 ± 0.2 A 7.2 ± 0.1 A 6.9 ± 0.2 A 
  Acid-adapted/pH 3.0 
E. coli surrogates  1.9 ± 0.1 A 4.3 ± 0.1 B 5.0 ± 0.2 B 6.1 ± 0.2 A 6.6 ± 0.2 A 
rif-resistant E. coli surrogates  1.9 ± 0.1 A 3.6 ± 0.1 C 4.4 ± 0.2 C 5.0 ± 0.2 B 5.6 ± 0.2 B 
Non-O157:H7 STECs  2.0 ± 0.1 A 4.7 ± 0.1 A 5.6 ± 0.2 A 6.3 ± 0.2 A 6.2 ± 0.2 AB 
  Acid adapted/pH 3.5 
E. coli surrogates  2.0 ± 0.0 A 2.2 ± 0.1 A 2.3 ± 0.1 A 2.5 ± 0.1 B 3.4 ± 0.1 A 
rif-resistant E. coli surrogates  2.0 ± 0.0 A 2.1 ± 0.1 A 2.2 ± 0.1 A 2.5 ± 0.1 B 2.9 ± 0.1 B 
Non-O157:H7 STECs  2.0 ± 0.0 A 2.1 ± 0.1 A 2.4 ± 0.1 A 2.8 ± 0.1 A 3.5 ± 0.1 A 
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Figure 2. Mean log reductions (CFU/ml) for sets of stationary phase E. coli biotype I 
surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 
exposure to phosphate buffered saline acidified with L-lactic acid at pH 3.0 at 37°C	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 372 
Figure 3. Mean log reductions (CFU/ml) for sets of stationary phase E. coli biotype I 373 
surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 374 
exposure to phosphate buffered saline acidified with L-lactic acid at pH 3.5 at 37°C 375 
 376 
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 378 
Figure 4. Mean log reductions (CFU/ml) for sets of acid-adapted E. coli biotype I 379 
surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 380 
exposure to phosphate buffered saline acidified with L-lactic acid at pH 2.5 at 37°C 381 
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 383 
Figure 5. Mean log reductions (CFU/ml) for sets of acid-adapted E. coli biotype I 384 
surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 385 
exposure to phosphate buffered saline acidified with L-lactic acid at pH 3.0 at 37°C 386 
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 388 
Figure 6. Mean log reductions (CFU/ml) for sets of acid-adapted E. coli biotype I 389 
surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 390 
exposure to phosphate buffered saline acidified with L-lactic acid at pH 3.5 at 37°C 391 
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Table 9 represents the sets of organisms that were analyzed together to create a 393 
mean for the E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and 394 
the non-O157 STECs, following 2-h exposure to the three individual pH values. The 395 
stationary phase organisms at pH value 2.5 were omitted due to the log reduction counts 396 
falling below the level of detection. For the first replication of the stationary phase 397 
organisms at pH 2.5, an initial count was not taken, and following the 0.5-h time point, 398 
organisms were below the level of detection. For the second and third replication of the 399 
stationary phase organisms at pH 2.5, an initial count was taken, and after the 0.5-h time 400 
point, organisms were below the level of detection. For the stationary phase organisms at 401 
pH 3.0 (Figure 7), there were no differences (P > 0.05) between the biotype I surrogates, 402 
rif-resistant biotype I surrogates, and the non-O157 STECs following a 2-h exposure to 403 
L-lactic acid. Stationary phase organisms at pH 3.5, showed no differences (P > 0.05) 404 
between the biotype I surrogates and the rif-resistant biotype I surrogates, but there was 405 
a difference (P < 0.05) with the non-O157 STECs, representing a greater log reduction 406 
count (CFU/ml) (3.4, 3.5 and 4.5 log reduction CFU/ml, respectively). Acid-adapted 407 
organisms at pH 2.5 (Figure 8) showed no differences (P > 0.05) between the biotype I 408 
surrogates, rif-resistant biotype I surrogates, and non-O157 STECs. Acid-adapted 409 
organisms at pH 3.0 showed no differences (P > 0.05) between the non-O157 STECs, 410 
and the biotype I surrogates and rif-resistant biotype I surrogates. At pH 3.5, acid- 411 
adapted biotype I surrogates were not different (P > 0.05) from the non-O157 STECs; 412 
however, the rif-resistant biotype I surrogates were different (P < 0.05). 413 
  414 
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Table 9. Mean reductions (log CFU/ml) for E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and 415 
non-O157 STECs strains after exposure to phosphate buffered saline acidified with L-lactic acid at 37°C 416 
 417 
 418 
 419 
 420 
 421 
 422 
 423 
 424 
 425 
 426 
 427 
 428 
 429 
 430 
 431 
Overall mean log reductions after 0, 0.5, 1.0, 1.5 and 2.0 h exposure 432 
a Mean values were obtained from three independent replicates 433 
b SEM = Standard error of the least squares means 434 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 435 
d E. coli surrogates include BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 strains 436 
e Rif-resistant E. coli surrogates include rif-resistant strains BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA- 437 
1431 438 
f BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 439 
O45:H2, BAA-2192 = O145:NM 440 
 441 
  442 
  Mean reductiona ± SEMb 
  pH 2.5 pH 3.0 pH 3.5 
Organism  Stationary 
E. coli surrogatesd  . 6.8 ± 0.2 Ac 3.4 ± 0.2 B 
rif-resistante E. coli surrogates  . 6.9 ± 0.2 A 3.1 ± 0.2 B 
Non-O157:H7 STECsf  . 6.9 ± 0.2 A 4.5 ± 0.2 A 
  Acid-adapted 
E. coli surrogates  6.9 ± 0.2 A 6.6 ± 0.2 A 3.4 ± 0.1 A 
rif-resistant E. coli surrogates  7.2 ± 0.2 A 5.6 ± 0.2 B 2.9 ± 0.1 B 
Non-O157:H7 STECs  6.9 ± 0.2 A 6.2 ± 0.2 AB 3.5 ± 0.1 A 
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 443 
Figure 7. Mean log reductions (CFU/ml) for sets of stationary phase E. coli biotype I 444 
surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 445 
exposure to phosphate buffered saline acidified with L-lactic acid for 2-h at 37°C 446 
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 448 
Figure 8. Mean log reductions (CFU/ml) for sets of acid-adapted E. coli biotype I 449 
surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 450 
exposure to phosphate buffered saline acidified with L-lactic acid for 2-h at 37°C 451 
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 453 
Thermal resistance 454 
Decimal reduction time (D-value) refers to the time (in minutes) required at a 455 
given temperature to kill 90% or 1-log of the exposed microorganisms. For a surrogate 456 
to properly represent the non-O157 STECs, the surrogate would ideally have a higher D- 457 
value compared to the non-O157 STECs. It would ideally take longer to kill the 458 
surrogate, and therefore, process would be sufficient to kill the non-O157 STECs. Table 459 
10 shows the D-values for the stationary phase organisms at three varying temperatures: 460 
55°, 60°, and 65°C. At 55°C, the D-values for the surrogates ranged from 10.3-19.6 461 
minutes, the rif-resistant surrogates ranged from 9.4-29.7 minutes, and the non-O157 462 
STECs ranged from 5.6-11.2 minutes. There were varying differences (P < 0.05) 463 
between the individual 16 organisms, but each non-O157 STEC was not significantly 464 
different (P > 0.05) from at least one of the biotype I surrogates. This may indicate that 465 
at 55°C, if the biotype I surrogate organisms have been reduced, the non-O157 STECs 466 
have also been reduced, which is an ideal characteristic of a surrogate organism. These 467 
data supports previously published data demonstrating that E. coli biotype I surrogates 468 
had the same (P > 0.05) or higher (P < 0.05) D-values when compared to E. coli 469 
O157:H7 (8).  470 
At 60°C, there were fewer differences (P < 0.05) between the individual 471 
organisms, and the D-values ranged from 0.4-1.4 minutes for the stationary organisms. 472 
BAA-1431 was the individual organism that had the highest D-value at 60°C at 1.4 473 
minutes for the biotype I surrogate. This would indicate that if organism BAA-1431 is 474 
reduced, the non-O157 STEC organism may also be reduced. Stationary organisms at 475 
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65°C had D-values ranging from 0.09-1.24 minutes. The low and high D-values both 476 
came from non-O157 STECs; therefore, indicating that at the higher temperature, 477 
following the reduction of the biotype I surrogate, the non-O157 STECs may not all be 478 
efficiently reduced. This may indicate that the biotype I surrogates may not represent the 479 
non-O157 STECs at 65°C. 480 
Z-values were calculated by taking the log of the D-values and plotting them as a 481 
function of temperature (55, 60, and 65°C). A z-value represents the degrees in either F 482 
or C that are required for the thermal destruction curve to traverse 1 log cycle, the 483 
change in temperature that changes the D-value by a factor of 10. The z-value reflects 484 
the relative resistance of an organism to different temperatures. The z-values for the 485 
stationary phase organisms are reported in Table 10. The z-values ranged from 4.9 to 486 
15.3. Organism BAA-2193 had the highest z-value (15.3), while BAA-1427 rif and 487 
BAA-1429 rif had the lowest z-value (4.9). Organism BAA-2193 was not different (P > 488 
0.05) from one of the rif-resistant E. coli biotype I surrogates (BAA-1430 rif). These 489 
data may demonstrate that the E. coli biotype I surrogates may not represent all of the 490 
non-O157 STECs appropriately. It may require a higher temperature change to destroy 491 
the non-O157 STECs than what is required to change the E. coli biotype I surrogates.  492 
Table 11 shows the D-values for the acid-adapted organisms at three varying 493 
temperatures: 55°, 60°, and 65°C. D-values at 55°C for all 16 organisms ranged from 494 
7.1-22.2 minutes. At 55°C, BAA-2219 had the highest D-value at 22.2 minutes, and it 495 
was not different (P > 0.05) from at least one biotype I surrogate, and at least one rif- 496 
resistant surrogate. At 60°C, acid-adapted organisms’ D-values ranged from 0.6-6.0 497 
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minutes, with BAA-2196 (5.3 minutes) and BAA-2217 (6.0 minutes) having the only 498 
different (P < 0.05) D-values from the remaining 14 organisms. This may indicate that 499 
by sufficiently reducing the biotype I surrogates at this temperature, all the non-O157 500 
STECs may not be efficiently reduced. At 65°C, acid-adapted organisms had D-values 501 
ranging from 0.13-0.64 minutes. At this temperature, organism BAA-1429 rif had the 502 
highest D-value (0.64 minutes), and organism BAA-2217 and BAA-2192 had the lowest 503 
D-value (0.13 minutes). In this case, at this temperature, data may show that by reducing 504 
the rif-resistant biotype I surrogates, the non-O157 STECs may also be sufficiently 505 
reduced.  506 
The z-values for the acid-adapted organisms are demonstrated in Table 11. The z- 507 
values ranged from 4.9 to 8.4. Organism BAA-2193 had the highest z-value (8.4) and 508 
BAA-2192 had the lowest (4.9). Both organisms (BAA-2193 and BAA-2192) were not 509 
different (P > 0.05) from at least one E. coli biotype I surrogate, both the parent and rif- 510 
resistant strains.  511 
Keeling et al. (28) reported no difference (P > 0.10) in D-values between the 512 
biotype I surrogate microorganisms and E. coli O157:H7 at 60 or 71.1°C. The D-value 513 
for the pathogenic strain was numerically lower at 60°C than any surrogate, but the 514 
difference was not (P > 0.10) significant (28). Keeling et al. (28) conducted thermal 515 
resistance evaluations in 80% lean ground beef. D-values have shown to differ between 516 
fat content among ground beef samples (28). Data presented here show thermal 517 
resistance evaluations performed in a laboratory setting. Although the results may be 518 
similar, it is important to note that when using a surrogate organism in comparison for a 519 
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validation study, the exact processing conditions must be carried out. For example, in the 520 
data presented here, the organisms were in capillary tubes, not inculcated on a tissue 521 
surface. The results may vary when a tissue surface is inoculated due to differing 522 
characteristics of the surface and how the organism responds. For use in a validation 523 
study, the organism must be observed in the exact processing condition to be the most 524 
accurate, since different responses may occur due to the inoculation procedure.  525 
Thermal death curves were constructed for sets of organisms (biotype I 526 
surrogates, rif-resistant biotype I surrogates, and non-O157 STECs) and fitted by linear 527 
regression (Figures 9-14). From the thermal death curves, D-values were calculated and 528 
compared among the sets of organisms (biotype I surrogates, rif-resistant biotype I 529 
surrogates, and non-O157 STECs). Table 12 represents the sets of organisms, including 530 
the biotype I surrogates, the rif-resistant biotype I surrogates, and the non-O157 STECs. 531 
Stationary phase organisms at 55°C showed a difference (P < 0.05) between the non- 532 
O157 STECs and the biotype I surrogates, and rif-resistant biotype I surrogates. The 533 
non-O157 STECs had a lower D-value (8.2 minutes) compared to the biotype I 534 
surrogates (14.6 minutes) and the rif-resistant biotype I surrogates (18.4 minutes). As 535 
shown by the individual organisms at this temperature, reducing the biotype I surrogates 536 
may also efficiently reduce the non-O157 STECs. Stationary phase organisms at 60°C 537 
showed no differences (P > 0.05) between the biotype I surrogates, rif-resistant biotype I 538 
surrogates, and the non-O157 STECs (0.6-0.9 minutes). Stationary phase organisms at 539 
65°C reported no differences between (P > 0.05) the biotype I surrogates and the rif- 540 
resistant biotype I surrogates, or between the rif-resistant surrogates and the non-O157 541 
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STECs. It is important to note that at this temperature, the non-O157 STECs had the 542 
highest D-value (0.69 minutes) compared to the biotype I surrogates (0.21 minutes), and 543 
the rif-resistant biotype I surrogates (0.33 minutes), demonstrating that reducing the 544 
biotype I surrogate organisms may not result in a reduction of the non-O157 STECs. Z- 545 
values for the stationary phase organisms demonstrated no difference (P > 0.05) between 546 
the non-O157 STECs (8.9) and the rif-resistant E. coli biotype I surrogates (6.2). There 547 
was a difference (P < 0.05) between the E. coli biotype I surrogates (5.6) and the non- 548 
O157 STECs (8.9). It is important to note that the non-O157 STECs had the highest z- 549 
value compared to the E. coli biotype I surrogates, both parent and rif-resistant. These 550 
data may demonstrate that it may take a larger increase in the temperature to destroy the 551 
non-O157 STECs when compared to the E. coli biotype I surrogates, which may indicate 552 
that the E. coli biotype I surrogates may not represent the non-O157 STECs 553 
appropriately.  554 
Acid-adapted organisms at 55°C showed no differences (P > 0.05) between the 555 
biotype I surrogates, rif-resistant biotype I surrogates, and the non-O157 STECs. The 556 
biotype I surrogates had the lowest D-value (9.6 minutes) compared to the rif-resistant 557 
biotype I surrogates (13.4 minutes) though the numbers are not different (P > 0.05). 558 
Acid-adapted organisms at 60°C showed a difference (P < 0.05) between the non-O157 559 
STECs (3.0 minutes), biotype I surrogate (1.5 minutes) and rif-resistant biotype I 560 
surrogates (1.2 minutes). The non-O157 STECs had the highest D-value indicating that a 561 
reduction in biotype I surrogates may not result in a reduction of non-O157 STECs. 562 
Acid-adapted organisms at 65°C showed no differences (P > 0.05) between the biotype I 563 
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surrogates (0.27 minutes), and the rif-resistant biotype I surrogates (0.42 minutes). There 564 
was no difference (P > 0.05) between the biotype I surrogates and the non-O157 STECs 565 
(0.25 minutes). The non-O157 STECs had the lowest D-value at this temperature, 566 
indicating that reducing the biotype I surrogate may reduce the non-O157 STECs. Z- 567 
values for the acid-adapted organisms showed no differences (P > 0.05) between the E. 568 
coli biotype I surrogates (6.5), rif-resistant E. coli biotype I surrogates (6.4), and the non- 569 
O157 STECs (6.1).   570 
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Table 10. Decimal reduction time (D-value) for stationary phase E. coli biotype I surrogates, rif-resistant E. coli 571 
biotype I surrogates, and non-O157 STECs strains in phosphate buffered saline at different temperatures 572 
a Decimal reduction time (D-value) represents three independent replicates 573 
b SEM = Standard error of the least squares means 574 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 575 
d rif = rif-resistant organism 576 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 577 
O45:H2, BAA-2192 = O145:NM   578 
  D-value (min)a ± SEMb  
Organism  55°C 60°C 65°C z-value 
BAA 1427  12.5 ± 4.9 BCc 0.5 ± 0.3 B 0.21 ± 0.37 ABC 5.8 ± 2.5 B 
BAA 1428  19.6 ± 4.9 ABC 0.5 ± 0.3 B 0.31 ± 0.37 ABC 5.4 ± 2.5 B 
BAA 1429  13.8 ± 4.9 BC 0.7 ± 0.3 AB 0.16 ± 0.37 BC 5.3 ± 2.5 B 
BAA 1430  10.3 ± 4.9 BC 1.2 ± 0.3 AB 0.17 ± 0.37 BC 6.0 ± 2.5 B 
BAA 1431  16.7 ± 4.9 ABC 1.4 ± 0.3 A 0.21 ± 0.37 ABC 5.7 ± 2.5 B 
BAA 1427 rifd  29.7 ± 4.9 A 0.7 ± 0.3 AB 0.15 ± 0.37 BC 4.9 ± 2.5 B 
BAA 1428 rif  22.6 ± 4.9 AB 0.4 ± 0.3 B 0.17 ± 0.37 BC 5.3 ± 2.5 B 
BAA 1429 rif  18.9 ± 4.9 ABC 0.5 ± 0.3 B 0.15 ± 0.37 BC 4.9 ± 2.5 B 
BAA 1430 rif  9.4 ± 4.9 BC 0.4 ± 0.3 B 0.83 ± 0.37 ABC 9.3 ± 2.5 AB 
BAA 1431 rif  11.3 ± 4.9 BC 0.8 ± 0.3 AB 0.35 ± 0.37 ABC 6.4 ± 2.5 B 
BAA-2219e  11.2 ± 4.9 BC 0.6 ± 0.3 B 1.21 ± 0.37 AB 8.9 ± 2.5 AB 
BAA-2217  8.0 ± 4.9 C 0.6 ± 0.3 B 0.64 ± 0.37 ABC 8.5 ± 2.5 AB 
BAA-2215  8.5 ± 4.9 BC 0.7 ± 0.3 AB 0.66 ± 0.37 ABC 8.2 ± 2.5 AB 
BAA-2196  8.6 ± 4.9 BC 0.4 ± 0.3 B 0.09 ± 0.37 C 5.1 ± 2.5 B 
BAA-2193  7.3 ± 4.9 C 0.8 ± 0.3 AB 1.24 ± 0.37 A 15.3 ± 2.5 A 
BAA-2192  5.6 ± 4.9 C 0.6 ± 0.3 B 0.30 ± 0.37 ABC 7.3 ± 2.5 B 
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Table 11. Decimal reduction time (D-value) for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli biotype I 579 
surrogates, and non-O157 STECs strains in phosphate buffered saline at different temperatures 580 
a Decimal reduction time (D-value) represents three independent replicates 581 
b SEM = Standard error of the least squares means 582 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 583 
d rif = rif-resistant organism 584 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 585 
O45:H2, BAA-2192 = O145:NM 586 
  587 
  D-value (min)a ± SEMb  
Organism  55°C 60°C 65°C z-value 
BAA 1427  7.9 ± 4.4 BCc 1.4 ± 0.9 B 0.15 ± 0.11 E 5.9 ± 0.6 BCD 
BAA 1428  13.7 ± 4.4 ABC 0.9 ± 0.9 B 0.18 ± 0.11 DE 5.4 ± 0.6 CD 
BAA 1429  7.1 ± 4.4 C 1.7 ± 0.9 B 0.18 ± 0.11 DE 6.3 ± 0.6 BCD 
BAA 1430  9.9 ± 4.4 ABC 1.9 ± 0.9 B 0.50 ± 0.11 ABCD 7.6 ± 0.6 AB 
BAA 1431  9.7 ± 4.4 ABC 1.5 ± 0.9 B 0.34 ± 0.11 ABCDE 7.1 ± 0.6 ABC 
BAA 1427 rifd  10.4 ± 4.4 ABC 1.2 ± 0.9 B 0.53 ± 0.11 ABC 6.1 ± 0.6 BCD 
BAA 1428 rif  8.5 ± 4.4 BC 1.4 ± 0.9 B 0.41 ± 0.11 ABCDE 7.3 ± 0.6 AB 
BAA 1429 rif  19.8 ± 4.4 AB 1.1 ± 0.9 B 0.64 ± 0.11 A 6.8 ± 0.6 ABC 
BAA 1430 rif  13.2 ± 4.4 ABC 0.6 ± 0.9 B 0.30 ± 0.11 BCDE 6.1 ± 0.6 BCD 
BAA 1431 rif  15.0 ± 4.4 ABC 1.6 ± 0.9 B 0.21 ± 0.11 CDE 5.6 ± 0.6 CD 
BAA-2219e  22.2 ± 4.4 A 1.5 ± 0.9 B 0.18 ± 0.11 DE 5.4 ± 0.6 CD 
BAA-2217  10.8 ± 4.4 ABC 6.0 ± 0.9 A 0.13 ± 0.11 E 5.5 ± 0.6 CD 
BAA-2215  10.1 ± 4.4 ABC 1.5 ± 0.9 B 0.29 ± 0.11 BCDE 6.4 ± 0.6 BCD 
BAA-2196  9.5 ± 4.4 BC 5.3 ± 0.9 A 0.20 ± 0.11 DE 5.9 ± 0.6 BCD 
BAA-2193  8.8 ± 4.4 BC 2.3 ± 0.9 B 0.58 ± 0.11 AB 8.4 ± 0.6 A 
BAA-2192  16.6 ± 4.4 ABC 1.2 ± 0.9 B 0.13 ± 0.11 E 4.9 ± 0.6 D 
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 588 
Figure 9. Thermal death curves for stationary phase E. coli biotype I surrogates, rif- 589 
resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure to 590 
phosphate buffered saline at 55°C. Each data point represents the mean count of three 591 
replicates of the strains. The dotted line represents the linear trendline of each survival 592 
curve. 593 
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 595 
Figure 10. Thermal death curves for stationary phase E. coli biotype I surrogates, rif- 596 
resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure to 597 
phosphate buffered saline at 60°C. Each data point represents the mean count of three 598 
replicates of the strains. The dotted line represents the linear trendline of each survival 599 
curve. 600 
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 602 
Figure 11. Thermal death curves for stationary phase E. coli biotype I surrogates, rif- 603 
resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure to 604 
phosphate buffered saline at 65°C. Each data point represents the mean count of three 605 
replicates of the strains. The dotted line represents the linear trendline of each survival 606 
curve. 607 
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 609 
Figure 12. Thermal death curves for acid-adapted E. coli biotype I surrogates, rif- 610 
resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure to 611 
phosphate buffered saline at 55°C. Each data point represents the mean count of three 612 
replicates of the strains. The dotted line represents the linear trendline of each survival 613 
curve. 614 
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 616 
Figure 13. Thermal death curves for acid-adapted E. coli biotype I surrogates, rif- 617 
resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure to 618 
phosphate buffered saline at 60°C. Each data point represents the mean count of three 619 
replicates of the strains. The dotted line represents the linear trendline of each survival 620 
curve. 621 
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 623 
Figure 14. Thermal death curves for acid-adapted E. coli biotype I surrogates, rif- 624 
resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure to 625 
phosphate buffered saline at 65°C. Each data point represents the mean count of three 626 
replicates of the strains. The dotted line represents the linear trendline of each survival 627 
curve. 628 
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Table 12. Decimal reduction time (D-value) for stationary phase and acid-adapted E. coli biotype I surrogates, rif- 630 
resistant E. coli biotype I surrogates, and non-O157 STECs strains in phosphate buffered saline at different 631 
temperatures 632 
a Decimal reduction time (D-value) represents three independent replicates 633 
b SEM = Standard error of the least squares means 634 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 635 
d E. coli surrogates include BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 strains 636 
e Rif-resistant E. coli surrogates include rif-resistant strains BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA- 637 
1431 638 
f BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = 639 
O45:H2, BAA-2192 = O145:NM 640 
 641 
 642 
  643 
 D-value (min)a ± SEMb  
 55°C 60°C 65°C z-value 
Organism Stationary 
E. coli surrogatesd 14.6 ± 2.2 Ac 0.9 ± 0.1 A 0.21 ± 0.16 B 5.6 ± 1.1 B 
rif-resistante E. coli surrogates 18.4 ± 2.2 A 0.6 ± 0.1 A 0.33 ± 0.16 AB 6.2 ± 1.1 AB 
Non-O157:H7 STECsf 8.2 ± 2.0 B 0.6 ± 0.1 A 0.69 ± 0.15 A 8.9 ± 1.0 A 
 Acid-adapted 
E. coli surrogates 9.6 ± 2.0 A 1.5 ± 0.5 B 0.27 ± 0.06 AB 6.5 ± 0.3 A 
rif-resistant E. coli surrogates 13.4 ± 2.0 A 1.2 ± 0.5 B 0.42 ± 0.06 A 6.4 ± 0.3 A 
Non-O157:H7 STECs 13.0 ± 1.8 A 3.0 ± 0.4 A 0.25 ± 0.05 B 6.1 ± 0.3 A 
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Response to refrigeration and freezing temperatures 644 
One of the characteristics of an ideal surrogate organism is having similar 645 
characteristics, including growth, resistance to acid and thermal, and response to 646 
refrigeration and freezing temperatures. Storage at low temperatures is necessary for 647 
meat and meat products, both in processing and for preservation. If a surrogate organism 648 
were to be used to represent the non-O157 STECs, it would ideally be similar in 649 
response to refrigeration and freezing temperatures. The organisms were grown in and 650 
cultured in both TSB (stationary phase) and TSB+G (acid-adapted) to determine if there 651 
was a difference or cross protection between inducing an acid-adaptation response.  652 
The mean counts (CFU/ml) for the E. coli biotype I surrogates, rif-resistant E. 653 
coli biotype I surrogates and non-O157 STECs, stationary phase and acid-adapted after 654 
storage at −20°C and 4°C during 0, 7, 14, 21, 28, 60, and 90 d, are presented in Tables 655 
13-16. Based on the results obtained, no one single E. coli biotype I surrogate 656 
represented the pathogenic non-O157 STECs survival properties at −20°C and 4°C. 657 
Strain to strain reactions to stress vary from organism to organism, and is an inherent 658 
property. Both refrigerated and frozen storage resulted in random differences between 659 
counts of E. coli biotype I microorganisms and non-O157 STECs; however, there were 660 
no notable trends or patterns observed.  661 
The ability to survive at low temperatures was also compared for the sets of 662 
organisms. The mean counts (CFU/ml) for the groups of E. coli biotype I surrogates, rif- 663 
resistant E. coli biotype I surrogates and non-O157 STECs, stationary phase and acid- 664 
adapted after storage at −20°C and 4°C during 0, 7, 14, 21, 28, 60, and 90 d, are 665 
  76 
presented in Tables 17 (Figures 15-18). By the completion of the 90 d storage period in 666 
phosphate buffered saline, all three sets of organisms at both conditions (stationary phase 667 
and acid-adapted) and at both temperatures (−20°C and 4°C) showed no differences (P > 668 
0.05). There were differences (P < 0.05) throughout the sampling period, but over time 669 
the organisms evened out and were not different (P > 0.05) following 90 d storage time 670 
at refrigerated and freezing temperatures.  671 
 77 
Table 13. Mean counts (log CFU/ml) for stationary phase E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 
exposure to phosphate buffered saline at −20°C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Mean values were obtained from three independent replicates 
b SEM = Standard error of the least squares means 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 
d rif = rif-resistant organism 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM 
  Meana ± SEMb 
  Time (days) 
Organism  0 7 14 21 28 60 90 
BAA 1427  7.8 ± 0.1 ABCDc 6.6 ± 0.2 ABC 6.0 ± 0.2 ABCD 5.4 ± 0.2 DEF 5.1 ± 0.2 D 4.9 ± 0.3 CDE 4.4 ± 0.3 BCD 
BAA 1428  7.8 ± 0.1 ABCD 6.4 ± 0.2 BC 5.8 ± 0.2 BCD 5.2 ± 0.2 F 5.1 ± 0.2 D 5.7 ± 0.3 AB 5.0 ± 0.3 ABC 
BAA 1429  7.9 ± 0.1 AB 7.1 ± 0.2 A 6.4 ± 0.2 AB 6.3 ± 0.2 A 6.0 ± 0.2 AB 6.0 ± 0.3 A 5.4 ± 0.3 A 
BAA 1430  8.0 ± 0.1 A 6.5 ± 0.2 ABC 5.6 ± 0.2 D 5.9 ± 0.2 ABCDE 5.0 ± 0.2 D 4.7 ± 0.3 DE 4.0 ± 0.3 D 
BAA 1431  7.7 ± 0.1 D 6.3 ± 0.2 BC 5.9 ± 0.2 BCD 5.4 ± 0.2 DEF 5.2 ± 0.2 CD 5.0 ± 0.3 BCDE 4.7 ± 0.3 ABCD 
BAA 1427 rifd  7.8 ± 0.1 BCD 6.9 ± 0.2 AB 6.5 ± 0.2 A 6.1 ± 0.2 ABC 6.1 ± 0.2 A 5.1 ± 0.3 BCDE 4.9 ± 0.3 ABCD 
BAA 1428 rif  7.7 ± 0.1 CD 6.5 ± 0.2 ABC 5.8 ± 0.2 BCD 5.6 ± 0.2 BCDEF 5.5 ± 0.2 BCD 5.6 ± 0.3 AB 4.5 ± 0.3 ABCD 
BAA 1429 rif  7.9 ± 0.1 AB 6.6 ± 0.2 ABC 6.2 ± 0.2 ABC 6.0 ± 0.2 ABCD 5.6 ± 0.2 ABC 5.0 ± 0.3 BCDE 4.5 ± 0.3 BCD 
BAA 1430 rif  7.8 ± 0.1 ABCD 6.5 ± 0.2 ABC 6.2 ± 0.2 ABC 5.5 ± 0.2 BCDEF 5.2 ± 0.2 CD 4.8 ± 0.3 CDE 5.0 ± 0.3 ABC 
BAA 1431 rif  7.8 ± 0.1 BCD 6.6 ± 0.2 ABC 6.3 ± 0.2 ABC 5.9 ± 0.2 ABCDE 5.4 ± 0.2 CD 5.5 ± 0.3 ABC 5.0 ± 0.3 ABC 
BAA-2219e  7.9 ± 0.1 ABC 6.6 ± 0.2 ABC 6.0 ± 0.2 ABCD 6.1 ± 0.2 AB 5.2 ± 0.2 CD 5.6 ± 0.3 AB 5.3 ± 0.3 AB 
BAA-2217  7.9 ± 0.1 AB 6.6 ± 0.2 ABC 5.9 ± 0.2 BCD 5.7 ± 0.2 ABCDEF 5.1 ± 0.2 CD 5.0 ± 0.3 BCDE 4.3 ± 0.3 CD 
BAA-2215  7.7 ± 0.1 CD 6.5 ± 0.2 BC 5.9 ± 0.2 ABCD 5.4 ± 0.2 EF 5.3 ± 0.2 CD 5.2 ± 0.3 BCD 4.7 ± 0.3 ABCD 
BAA-2196  7.4 ± 0.1 E 6.1 ± 0.2 C 5.6 ± 0.2 D 5.4 ± 0.2 CDEF 5.1 ± 0.2 CD 4.8 ± 0.3 DE 4.4 ± 0.3 BCD 
BAA-2193  7.8 ± 0.1 BCD 6.4 ± 0.2 BC 5.5 ± 0.2 D 5.2 ± 0.2 F 5.2 ± 0.2 CD 4.4 ± 0.3 E 4.3 ± 0.3 CD 
BAA-2192  7.9 ± 0.1 AB 6.1 ± 0.2 C 5.7 ± 0.2 CD 5.2 ± 0.2 F 5.1 ± 0.2 CD 4.6 ± 0.3 DE 4.8 ± 0.3 ABCD 
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Table 14. Mean counts (log CFU/ml) for stationary phase E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after 699 
exposure to phosphate buffered saline at 4°C 700 
 701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
 711 
 712 
 713 
 714 
 715 
 716 
 717 
 718 
 719 
 720 
a Mean values were obtained from three independent replicates 721 
b SEM = Standard error of the least squares means 722 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 723 
d rif = rif-resistant organism 724 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM 725 
  Meana ± SEMb 
  Time (days) 
Organism  0 7 14 21 28 60 90 
BAA 1427  8.0 ± 0.1 Ac 7.7 ± 0.1 ABC 7.7 ± 0.1 AB 7.6 ± 0.1 AB 7.6 ± 0.1 BC 7.3 ± 0.1 ABC 7.2 ± 0.1 B 
BAA 1428  7.8 ± 0.1 ABC 7.8 ± 0.1 A 7.6 ± 0.1 AB 7.5 ± 0.1 ABC 7.6 ± 0.1 BC 7.2 ± 0.1 CD 6.7 ± 0.1 CD 
BAA 1429  8.0 ± 0.1 A 7.7 ± 0.1 ABC 7.7 ± 0.1 A 7.7 ± 0.1 A 7.9 ± 0.1 A 7.5 ± 0.1 A 6.9 ± 0.1 C 
BAA 1430  8.0 ± 0.1 A 7.7 ± 0.1 ABCD 7.5 ± 0.1 AB 7.5 ± 0.1 ABC 7.4 ± 0.1 BCD 7.1 ± 0.1 CDE 6.7 ± 0.1 CD 
BAA 1431  7.6 ± 0.1 DE 7.4 ± 0.1 EF 7.2 ± 0.1 D 7.1 ± 0.1 DE 6.9 ± 0.1 GH 6.7 ± 0.1 FG 6.6 ± 0.1 D 
BAA 1427 rifd  7.9 ± 0.1 AB 7.5 ± 0.1 CDE 7.3 ± 0.1 CD 7.2 ± 0.1 CD 7.1 ± 0.1 EFG 6.8 ± 0.1 FG 6.7 ± 0.1 CD 
BAA 1428 rif  7.6 ± 0.1 F 7.6 ± 0.1 BCDE 7.5 ± 0.1 AB 7.3 ± 0.1 BCD 7.5 ± 0.1 BCD 7.3 ± 0.1 BCD 7.4 ± 0.1 A 
BAA 1429 rif  7.8 ± 0.1 ABCD 7.8 ± 0.1 AB 7.5 ± 0.1 BC 7.4 ± 0.1 BCD 7.2 ± 0.1 DEF 6.8 ± 0.1 FG 6.7 ± 0.1 CD 
BAA 1430 rif  7.8 ± 0.1 BCD 7.4 ± 0.1 DEF 7.2 ± 0.1 D 7.1 ± 0.1 DE 7.0 ± 0.1 FGH 6.7 ± 0.1 FG 6.6 ± 0.1 D 
BAA 1431 rif  7.8 ± 0.1 ABCD 7.6 ± 0.1 ABCDE 7.3 ± 0.1 CD 7.2 ± 0.1 D 7.1 ± 0.1 EFGH 6.8 ± 0.1 FG 6.6 ± 0.1 D 
BAA-2219e  7.8 ± 0.1 ABCD 7.8 ± 0.1 AB 7.7 ± 0.1 AB 7.6 ± 0.1 AB 7.5 ± 0.1 BC 6.7 ± 0.1 FG 6.6 ± 0.1 D 
BAA-2217  8.0 ± 0.1 A 7.8 ± 0.1 A 7.7 ± 0.1 A 7.6 ± 0.1 AB 7.7 ± 0.1 AB 7.1 ± 0.1 DE 6.6 ± 0.1 D 
BAA-2215  7.7 ± 0.1 CDE 7.4 ± 0.1 EF 7.3 ± 0.1 CD 7.3 ± 0.1 CD 7.3 ± 0.1 CDE 6.9 ± 0.1 EF 6.7 ± 0.1 CD 
BAA-2196  7.5 ± 0.1 E 7.2 ± 0.1 F 6.9 ± 0.1 E 6.8 ± 0.1 EF 6.8 ± 0.1 HI 6.6 ± 0.1 G 6.6 ± 0.1 D 
BAA-2193  7.9 ± 0.1 AB 7.8 ± 0.1 A 7.6 ± 0.1 AB 7.7 ± 0.1 A 7.6 ± 0.1 ABC 7.5 ± 0.1 AB 7.2 ± 0.1 AB 
BAA-2192  7.9 ± 0.1 AB 7.4 ± 0.1 EF 6.8 ± 0.1 E 6.6 ± 0.1 F 6.6 ± 0.1 I 6.6 ± 0.1 G 6.6 ± 0.1 D 
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Table 15. Mean counts (log CFU/ml) for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure 726 
to phosphate buffered saline at −20°C 727 
 728 
 729 
 730 
 731 
 732 
 733 
 734 
 735 
 736 
 737 
 738 
 739 
 740 
 741 
 742 
 743 
 744 
 745 
 746 
 747 
a Mean values were obtained from three independent replicates 748 
b SEM = Standard error of the least squares means 749 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 750 
d rif = rif-resistant organism 751 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM   752 
  Meana ± SEMb 
  Time (days) 
Organism  0 7 14 21 28 60 90 
BAA 1427  7.8 ± 0.1 ABCDc 5.9 ± 0.2 ABCDE 5.4 ± 0.2 BCD 5.0 ± 0.1 B 4.7 ± 0.2 BCD 4.3 ± 0.3 CDE 3.9 ± 0.4 ABCD 
BAA 1428  8.0 ± 0.1 A 5.5 ± 0.2 E 5.0 ± 0.2 D 5.0 ± 0.1 B 4.2 ± 0.2 D 4.4 ± 0.3 BCDE 3.5 ± 0.4 CD 
BAA 1429  7.9 ± 0.1 ABC 6.3 ± 0.2 AB 6.2 ± 0.2 A 5.3 ± 0.1 AB 4.8 ± 0.2 ABCD 4.7 ± 0.3 ABCDE 4.8 ± 0.4 A 
BAA 1430  7.9 ± 0.1 AB 5.7 ± 0.2 CDE 5.1 ± 0.2 CD 5.0 ± 0.1 B 4.1 ± 0.2 D 4.6 ± 0.3 BCDE 3.3 ± 0.4 D 
BAA 1431  7.4 ± 0.1 DE 5.8 ± 0.2 CDE 5.2 ± 0.2 CD 5.0 ± 0.1 B 4.4 ± 0.2 CD 4.3 ± 0.3 CDE 3.8 ± 0.4 ABCD 
BAA 1427 rifd  7.6 ± 0.1 BCDE 5.9 ± 0.2 BCDE 5.5 ± 0.2 BCD 5.1 ± 0.1 B 5.3 ± 0.2 AB 4.6 ± 0.3 BCDE 4.3 ± 0.4 ABCD 
BAA 1428 rif  7.8 ± 0.1 ABCD 6.4 ± 0.2 A 5.6 ± 0.2 ABCD 5.4 ± 0.1 AB 5.5 ± 0.2 A 5.4 ± 0.3 A 3.9 ± 0.4 ABCD 
BAA 1429 rif  7.7 ± 0.1 ABCD 6.0 ± 0.2 ABCD 5.2 ± 0.2 CD 5.1 ± 0.1 AB 4.8 ± 0.2 ABCD 4.8 ± 0.3 ABCD 3.7 ± 0.4 BCD 
BAA 1430 rif  7.5 ± 0.1 DE 5.6 ± 0.2 DE 5.4 ± 0.2 BCD 5.0 ± 0.1 B 4.3 ± 0.2 CD 4.1 ± 0.3 DE 3.6 ± 0.4 BCD 
BAA 1431 rif  7.5 ± 0.1 CDE 5.9 ± 0.2 ABCDE 5.4 ± 0.2 BCD 5.0 ± 0.1 B 4.5 ± 0.2 CD 4.6 ± 0.3 BCDE 3.5 ± 0.4 CD 
BAA-2219e  7.8 ± 0.1 ABCD 6.2 ± 0.2 ABC 5.5 ± 0.2 BCD 5.0 ± 0.1 B 4.6 ± 0.2 BCD 5.1 ± 0.3 AB 4.4 ± 0.4 ABC 
BAA-2217  7.8 ± 0.1 ABCD 6.1 ± 0.2 ABC 5.7 ± 0.2 ABC 5.5 ± 0.1 A 4.2 ± 0.2 D 4.0 ± 0.3 E 3.5 ± 0.4 CD 
BAA-2215  7.6 ± 0.1 BCDE 6.0 ± 0.2 ABCDE 5.2 ± 0.2 CD 5.1 ± 0.1 AB 4.8 ± 0.2 BCD 4.9 ± 0.3 ABC 4.4 ± 0.4 ABC 
BAA-2196  7.3 ± 0.1 E 6.1 ± 0.2 ABCD 5.2 ± 0.2 CD 5.4 ± 0.1 AB 4.9 ± 0.2 ABC 4.8 ± 0.3 ABC 4.6 ± 0.4 AB 
BAA-2193  7.8 ± 0.1 ABCD 6.1 ± 0.2 ABCD 5.9 ± 0.2 AB 5.0 ± 0.1 B 4.6 ± 0.2 BCD 4.9 ± 0.3 ABC 3.7 ± 0.4 BCD 
BAA-2192  7.8 ± 0.1 ABCD 5.8 ± 0.2 BCDE 5.5 ± 0.2 BCD 5.1 ± 0.1 B 4.6 ± 0.2 BCD 4.0 ± 0.3 E 3.6 ± 0.4 BCD 
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Table 16. Mean counts (log CFU/ml) for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure 753 
to phosphate buffered saline at 4°C 754 
 755 
a Mean values were obtained from three independent replicates 756 
b SEM = Standard error of the least squares means 757 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 758 
d rif = rif-resistant organism 759 
e BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM    760 
  Meana ± SEMb 
  Time (days) 
Organism  0 7 14 21 28 60 90 
BAA 1427  7.8 ± 0.1 ABc 7.7 ± 0.1 A 7.6 ± 0.1 A 7.7 ± 0.1 A 7.6 ± 0.1 AB 7.6 ± 0.1 A 7.5 ± 0.1 A 
BAA 1428  7.5 ± 0.1 F 7.2 ± 0.1 DE 6.8 ± 0.1 EFG 6.7 ± 0.1 EF 6.6 ± 0.1 H 6.6 ± 0.1 EF 6.4 ± 0.1 CDEF 
BAA 1429  7.9 ± 0.1 A 7.4 ± 0.1 BC 7.1 ± 0.1 CD 7.4 ± 0.1 C 7.2 ± 0.1 DE 7.2 ± 0.1 BCD 7.0 ± 0.1 B 
BAA 1430  7.8 ± 0.1 AB 7.4 ± 0.1 BC 7.0 ± 0.1 DE 7.0 ± 0.1 D 6.9 ± 0.1 FG 6.9 ± 0.1 DE 6.5 ± 0.1 CDE 
BAA 1431  7.6 ± 0.1 EF 7.1 ± 0.1 DE 6.7 ± 0.1 FG 6.7 ± 0.1 EF 6.7 ± 0.1 H 6.2 ± 0.1 G 6.1 ± 0.1 F 
BAA 1427 rifd  7.5 ± 0.1 F 7.0 ± 0.1 EF 6.9 ± 0.1 DEF 6.8 ± 0.1 DE 6.7 ± 0.1 H 6.5 ± 0.1 FG 6.1 ± 0.1 F 
BAA 1428 rif  7.7 ± 0.1 CDEF 7.5 ± 0.1 AB 7.6 ± 0.1 A 7.5 ± 0.1 C 7.5 ± 0.1 ABC 7.5 ± 0.1 AB 7.5 ± 0.1 A 
BAA 1429 rif  7.6 ± 0.1 DEF 7.0 ± 0.1 EF 6.7 ± 0.1 FG 6.8 ± 0.1 EF 6.6 ± 0.1 H 6.6 ± 0.1 EF 6.3 ± 0.1 DEF 
BAA 1430 rif  7.5 ± 0.1 F 6.9 ± 0.1 F 6.6 ± 0.1 G 6.6 ± 0.1 F 6.6 ± 0.1 H 6.2 ± 0.1 G 5.7 ± 0.1 G 
BAA 1431 rif  7.6 ± 0.1 DEF 7.0 ± 0.1 EF 6.6 ± 0.1 FG 6.6 ± 0.1 F 6.7 ± 0.1 H 6.6 ± 0.1 EF 6.5 ± 0.1 CDE 
BAA-2219e  7.8 ± 0.1 ABC 7.7 ± 0.1 A 7.4 ± 0.1 AB 7.5 ± 0.1 BC 7.4 ± 0.1 CD 7.1 ± 0.1 CD 6.3 ± 0.1 EF 
BAA-2217  7.6 ± 0.1 DEF 7.5 ± 0.1 AB 7.6 ± 0.1 A 7.5 ± 0.1 BC 7.4 ± 0.1 BCD 7.0 ± 0.1 CD 6.4 ± 0.1 CDEF 
BAA-2215  7.6 ± 0.1 EF 7.3 ± 0.1 CD 7.0 ± 0.1 CDE 7.0 ± 0.1 D 7.0 ± 0.1 EF 7.0 ± 0.1 CD 6.7 ± 0.1 BCD 
BAA-2196  7.2 ± 0.1 G 7.0 ± 0.1 EF 6.8 ± 0.1 EFG 6.7 ± 0.1 EF 6.8 ± 0.1 GH 6.8 ± 0.1 DEF 6.8 ± 0.1 BC 
BAA-2193  7.7 ± 0.1 BCDE 7.5 ± 0.1 ABC 7.5 ± 0.1 AB 7.7 ± 0.1 AB 7.7 ± 0.1 A 7.6 ± 0.1 A 7.5 ± 0.1 A 
BAA-2192  7.7 ± 0.1 ABCD 7.5 ± 0.1 AB 7.3 ± 0.1 BC 7.5 ± 0.1 C 7.4 ± 0.1 CD 7.3 ± 0.1 ABC 7.0 ± 0.1 B 
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Table 17. Mean counts (log CFU/ml) for E. coli biotype I surrogates, rif-resistant E. coli biotype I surrogates, and non-O157 STECs strains after exposure to 761 
phosphate buffered saline stored at low temperatures 762 
 763 
 764 
 765 
 766 
 767 
 768 
 769 
 770 
 771 
 772 
 773 
 774 
 775 
 776 
 777 
 778 
a Mean values were obtained from three independent replicates 779 
b SEM = Standard error of the least squares means 780 
c Means in the same column with the same letter (ABCDEFG) are not different (P > 0.05) 781 
d E. coli surrogates include BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 strains 782 
e Rif-resistant E. coli surrogates include rif-resistant strains BAA-1427, BAA-1428, BAA-1429, BAA-1430 and BAA-1431 783 
f BAA-2219 = O121:H19, BAA-2217 = O111, BAA-2215 = O103:H11, BAA-2196 = O26:H11, BAA-2193 = O45:H2, BAA-2192 = O145:NM 784 
 Mean reductiona ± SEMb 
  Time (days) 
 0 7 14 21 28 60 90 
Organism Stationary/−20°C 
E. coli surrogatesd 7.8 ± 0.0 Ac 6.6 ± 0.1 A 5.9 ± 0.1 AB 5.6 ± 0.1 AB 5.3 ± 0.1 B 5.3 ± 0.1 A 4.7 ± 0.2 A 
rif-resistante E. coli surrogates 7.8 ± 0.0 A 6.6 ± 0.1 A 6.2 ± 0.1 A 5.8 ± 0.1 A 5.6 ± 0.1 A 5.2 ± 0.1 A 4.8 ± 0.2 A 
Non-O157:H7 STECsf 7.8 ± 0.0 A 6.4 ± 0.1 A 5.8 ± 0.1 B 5.5 ± 0.1 B 5.2 ± 0.1 B 4.9 ± 0.1 A 4.6 ± 0.1 A 
 Stationary/4°C 
E. coli surrogates 7.9 ± 0.0 A 7.7 ± 0.1 A 7.5 ± 0.1 A 7.5 ± 0.1 A 7.5 ± 0.1 A 7.2 ± 0.1 A 6.8 ± 0.1 A 
rif-resistant E. coli surrogates 7.8 ± 0.0 A 7.6 ± 0.1 A 7.4 ± 0.1 AB 7.3 ± 0.1 B 7.2 ± 0.1 B 6.9 ± 0.1 B 6.8 ± 0.1 A 
Non-O157:H7 STECs 7.8 ± 0.0 A 7.6 ± 0.1 A 7.3 ± 0.1 B 7.3 ± 0.1 AB 7.3 ± 0.1 AB 6.9 ± 0.1 B 6.7 ± 0.1 A 
 Acid-adapted/−20°C 
E. coli surrogates 7.8 ± 0.1 A 5.8 ± 0.1 A 5.4 ± 0.1 A 5.1 ± 0.1 A 4.4 ± 0.1 B 4.5 ± 0.1 A 3.9 ± 0.2 A 
rif-resistant E. coli surrogates 7.6 ± 0.1 B 6.0 ± 0.1 A 5.4 ± 0.1 A 5.1 ± 0.1 A 4.9 ± 0.1 A 4.7 ± 0.1 A 3.8 ± 0.2 A 
Non-O157:H7 STECs 7.7 ± 0.1 AB 6.0 ± 0.1 A 5.5 ± 0.1 A 5.2 ± 0.1 A 4.6 ± 0.1 AB 4.6 ± 0.1 A 4.0 ± 0.2 A 
 Acid-adapted/4°C 
E. coli surrogates 7.7 ± 0.0 A 7.4 ± 0.1 A 7.0 ± 0.1 AB 7.1 ± 0.1 AB 7.0 ± 0.1 B 6.9 ± 0.1 AB 6.7 ± 0.1 A 
rif-resistant E. coli surrogates 7.6 ± 0.0 B 7.1 ± 0.1 B 6.9 ± 0.1 B 6.9 ± 0.1 B 6.8 ± 0.1 B 6.7 ± 0.1 B 6.4 ± 0.1 A 
Non-O157:H7 STECs 7.6 ± 0.0 AB 7.4 ± 0.1 A 7.3 ± 0.1 A 7.3 ± 0.1 A 7.3 ± 0.1 A 7.1 ± 0.1 A 6.8 ± 0.1 A 
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Figure 15. Mean counts for stationary phase E. coli biotype I surrogates, rif-resistant E. 
coli biotype I surrogates, and non-O157 STECs strains after exposure to phosphate 
buffered saline stored at −20°C	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 790 
Figure 16. Mean counts for stationary phase E. coli biotype I surrogates, rif-resistant E. 791 
coli biotype I surrogates, and non-O157 STECs strains after exposure to phosphate 792 
buffered saline stored at 4°C 793 
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 795 
Figure 17. Mean counts for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli 796 
biotype I surrogates, and non-O157 STECs strains after exposure to phosphate buffered 797 
saline stored at −20°C 798 
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 801 
Figure 18. Mean counts for acid-adapted E. coli biotype I surrogates, rif-resistant E. coli 802 
biotype I surrogates, and non-O157 STECs strains after exposure to phosphate buffered 803 
saline stored at 4°C 804 
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5. CONCLUSIONS 807 
 808 
These data suggest that E. coli biotype I surrogates may be used to predict 809 
growth, acid, and thermal resistance, and storage conditions of non-O157 STECs within 810 
a small amount of error. Findings for growth, acid, and thermal resistance, and storage 811 
conditions support previous research stating that surrogates may best be used as cocktail 812 
rather than as single strains (8, 19, 29). The beef industry may use these data to conduct 813 
in-plant validation studies to determine the efficacy of antimicrobial interventions on 814 
both E. coli O157:H7 and non-O157 STECs, and these data may also assist the beef 815 
industry in fulfilling regulatory expectations.  816 
USDA-FSIS requires scientific validation on interventions, and has published 817 
draft guidelines for in-plant validations. Rif-resistant E. coli biotype I surrogates are not 818 
recommended for use by FSIS for in-plant validation. Antibiotic resistant organisms are 819 
useful in laboratory settings to eliminate potential background microflora, and allow for 820 
the researcher to prove that the organisms that were used for the inoculation procedure 821 
are the same organisms that are recovered. The biotype I surrogates, if taken into a plant 822 
for use in a validation study, may be used to inoculate the product at a high rate. For 823 
example, the inoculum used may be close to 108 log CFU/ml. The benefit in this 824 
application, although not necessarily representative of what may be coming into a plant 825 
on a daily basis, is to be able to show reductions, and help in maneuvering different 826 
processing steps. The use of the higher inoculation procedure and attachment may allow 827 
a facility to evaluate their interventions and determine if the use of their antimicrobial 828 
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spray is appropriate, or does it need to be altered. A higher inoculation attachment also 829 
allows the facility to show a greater reduction or kill or microorganisms, which is useful 830 
in validating a system.  831 
The biotype I surrogates (parents strains) are approved for use in a facility by 832 
FSIS to validate a system; however, FSIS recommends that the use of bacterial surrogate 833 
strains that have been “marked” using an antibiotic resistant genes be avoided (35). The 834 
surrogates are nonpathogenic, and have been shown by the data in this study to be 835 
appropriate for use to represent the non-O157 STECs. The non-O157 STECs can cause 836 
illness, and it is important for processing facilities to validate their systems for these 837 
organisms. These data may help support decisions related to food safety programs in 838 
beef slaughter and further processing establishments. Continued data collection will 839 
provide information critical for use of the surrogates in validation studies. 840 
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APPENDIX 964
CERTIFICATE OF ANALYSIS 
93 
ATCC➢ Number: 
BAA-2217™ 
Lot Number:  
61161460 
Escherichia coli Strain 10C-3114 
Bacterial  cells suspended in an appropriate cryoprotectant 
07/31/2017 
2°C to 8°C for freeze-dried  cultures; - 80°C or colder for 
Organism: 
Product  Format:  
Expiration Date:  
Storage Conditions:  
frozen cultures 
Note: Do not store frozen vials in freezers with a 
defrost cycle, as this will expose the vials to 
increased  temperatures. 
Test Specification Result 
Gram stain and 
cell morphology 
Gram stain and cell morphology are consistent with 
the organism being tested. 
Gram negative, motile, 
rods in singles and pairs. 
Colony 
description 
Colony description is consistent with the organism 
being tested. 
Circular, entire, low convex, 
translucent. 
Purity Sample material is inoculated onto non-selective 
media. Cultures are examined macroscopically and 
microscopically after incubation. Cultures show no 
evidence of aberrant growth. 
No evidence of aberrant 
growth. 
Viability Sample material is checked for titer.  Results are 
≥ 106 cfu/vial, ccu/vial, or bacteria/vial. 
3.5  x 109 cfu/vial 
Phenotypic 
testing 
Sample material is evaluated with a defined 
battery of phenotypic tests including evaluation by 
bioMérieux VITEK® 2 Compact.  Results are 
consistent with the 
organism being tested. 
Catalase – positive 
Oxidase – negative 
Pigment Production – 
negative 
MacConkey agar growth - 
positive 
99% identification to 
Escherichia coli 
using bioMérieux VITEK® 2 
Compact 
Confirmed O146 serogroup
Genotypic 
testing 
Sample material is evaluated by 16S ribosomal 
gene sequencing and by PCR profile for select 
virulence genes.  Results are consistent with the 
organism being tested. 
Identification is 
consistent with the 
organism being tested 
Positive for stx2 gene; 
Negative for eae 
and stx1 genes 
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